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Genomic imprinting is a special form of epigenetic modification of the genome in 
which gene expression differs in an allele-specific manner depending on the parent-of-
origin. The degree of imprinting is often tissue- and/or developmental stage-specific, 
and may be altered in some diseases including cancer. To date, 99 genes have been 
shown to undergo genomic imprinting in mouse, and 60 are imprinted in humans, with 
an overlapping set of 43 imprinted in both species. This list is far from complete, and 
obtaining an exhaustive identification of imprinted genes would expand our 
understanding of the regulation and evolution of the phenomenon. To search for novel 
imprinted genes, I applied custom SNP microarray and Illumina mRNA sequencing 
technologies to the transcriptomes of reciprocal F1 mouse brains and placentas. In 
brain, I identified 26 genes with parent-of-origin dependent differential allelic 
expression. Pyrosequencing verified 17 of them, including three novel imprinted 
genes. In placenta, I confirmed the imprinting status of 23 known imprinted genes, and 
found that 12 genes reported previously to be imprinted in other tissues are also 
imprinted in placenta. Through a well-replicated design using an orthogonal allelic-
expression technology, I verified five novel imprinted genes that were not previously 
known to be imprinted in mouse. After repeated application to multiple tissues and 
developmental stages this approach will yield a complete catalog of imprinted genes, 
shedding light on the mechanism and evolution of imprinted genes and diseases 
associated with genomic imprinting.  
 
X-inactivation in female eutherian mammals has long been considered to occur at 
random in embryonic and postnatal tissues. After RNA-seq data revealed what 
appeared to be a chromosome-wide bias toward under-expression of paternal alleles in 
mouse tissue, I applied pyrosequencing to mouse brain cDNA samples from reciprocal 
cross F1 progeny of divergent strains, and found a small but consistent and highly 
statistically significant tendency to under-express the paternal X chromosome. Allelic 
bias in expression is also influenced by the sampling effect of X inactivation and by 
cis-acting regulatory variation, and for each gene we quantified the contributions of 
these effects in two different strain combinations while controlling for variability in 
Xce alleles. 
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CHAPTER 1  
Testing the imprinting status of candidate imprinted genes using custom SNP 
arrays in mouse neonatal brain 
 
Abstract 
 
Imprinted genes are a subset of genes that are expressed in a parent-of-origin 
dependent manner. To date 99 genes have been shown to undergo imprinting in 
mouse, and 60 genes are imprinted in humans, with only 43 of these genes being 
imprinted in both species (http://igc.otago.ac.nz/home.html). We know that these lists 
are incomplete. Genome-wide screens for imprinted genes in humans have suffered 
from insufficient sample size to get reciprocal transmission of the two parental alleles 
and lack of appropriate tissue for assay (clearest cases of imprinting occur in fetal 
brain and placenta). Our goal is to discover novel imprinted genes in mouse and test 
the imprinting status of their human orthologs. I chose two mouse strains among the 
15 with genome sequence information and extracted total RNA from post-natal day 2 
brains of both parents and the reciprocal F1s. 181 genes were selected as candidate 
genes from 600 putative mouse imprinted genes predicted by Leudi et al. 2005. 
Additional candidates were selected among orthologs of 63 potentially imprinted 
genes in humans (identified by uniparental expression in collaboration with Perlegen). 
Then I designed 25-mer oligo probes for a total of 396 exonic SNPs in the test genes 
and had a microarray prepared by Agilent. By hybridizing the Cy3 and Cy5 labeled 
cRNA made from the RNA samples to this microarray, the relative abundance of the 
two SNP alleles was quantified in the two reciprocal F1 strains. The data analysis 
identifies 10 candidate imprinted genes, all of which have lower fold-change 
compared to the known imprinted gene controls. I verified novel candidates in mouse 
 2 
using pyrosequencing method, and found none of them were imprinted. Given that I 
observed expected results for the positive and negative control genes, I conclude that 
the computation prediction method has very little power and extremely high false 
positive rate for discovering novel imprinted genes.  
  
 3 
Introduction 
 
Genomic imprinting is a remarkable epigenetic phenomenon. At a small number of 
mammalian loci, only one of the two alleles is expressed, or one of the two alleles is 
predominantly expressed. The gist is that gene expression depends on the sex of the 
transmitting parent. These genes are called imprinted genes. Some inheritable 
molecular imprints, for example, differential methylation, or histone modification, are 
established on the paternal or maternal allele to repress the expression of one allele. 
The imprinting status of an imprinted gene is often tissue specific and/or 
developmental stage specific, and may be altered in human diseases including cancer.  
 
In 2005, there are 96 imprinted genes in mouse genome, including non-coding 
transcript, snoRNA and miRNA, which belong to 83 transcriptional units defined by 
Marison et al. 2005 (Figure 1). 54 of them are maternally expressed and 42 of them 
show paternal specific expression. In the human genome, there are 53 known 
imprinted genes which belong to 41 transcriptional units. 19 of them are only 
maternally expressed and 34 of them show paternal specific expression. 37 genes (29 
transcriptional units) are imprinted in both human and mouse. 1 of the 37 genes, Zim2, 
is reported to be oppositely imprinted in human and mouse. It is estimated that about 
1% of the genes in human genome are imprinted, which is around 200 genes (Murphy 
and Jirtle 2003). So there are still 100 imprinted genes to be discovered.  
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Figure 1. Summary of known imprinted genes in human and mouse. Data from 
Morison et al. 2005. TU: transcription units. The term TU has been defined as 
a group of transcripts that contain a common core of genetic information 
having the same orientation, which does not necessarily correspond to 
protein-coding regions. 
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Using a machine learning approach, Luedi et al. 2005 predicted 600 genes out of a 
total of 23,788 annotated autosomal genes in mouse to be imprinted (2.5%); 384 
(64%) of these candidate imprinted genes were predicted to exhibit maternal 
expression. Here, to identify novel imprinted genes, I selected a subset of the predicted 
imprinted genes, designed a custom SNP microarray and hybridized to cRNAs from 
reciprocal F1 mouse brain samples of two different cross combinations. 10 candidate 
genes from the microarray results were chosen for allele-specific pyrosequencing 
verification and none of them are imprinted. The results suggest that the computation 
prediction method has very little power and suffers from extremely high false positive 
rate. 
   
  
 6 
Materials and Methods 
 
Mouse Strain and tissue selection 
Because most of the imprinted genes are imprinted and expressed in brain and 
placenta, I choose the neonatal brain as the testing tissue. Two mouse strain 
combinations are selected to maximize the 600 predicted imprinted genes covered by 
our study. Four mouse strains (C57BL/6, C3H/HeJ, AKR/J, PWD/PhJ) were 
purchased from the Jackson Laboratory (www.jax.org). I performed two pairs of 
mouse reciprocal crosses (C57BL/6 x C3H/HeJ, C3H/HeJ x C57BL/6, AKR/J x 
PWD/PhJ, PWD/PhJ x AKR/J). Total RNA samples were extracted from the P2 F1 
mouse whole brains using the Qiagen RNeasy Mini Kit. RNA concentrations and A260 
nm/A280 nm ratios were checked with a NanoDrop ND-1000 Spectrophotometer. RNA 
integrity was checked using the Agilent 2100 Bioanalyzer. All of the samples have a 
RIN (RNA integrity number) of 10.   
 
All procedures involving mice have been approved by the Institutional Animal Care 
and Use Committee at Cornell University (protocol number 2002-0075, approved for 
three years beginning 01/27/2006).  Cornell University is accredited by AAALAC. 
 
Selection of candidate and positive/negative control genes 
I selected genes from the 600 predicted imprinted gene list with SNPs in the 
transcripts between the two strain combinations. The SNP information was 
downloaded from three mouse SNP databases. The first is the Mouse Genome 
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Informatics (MGI) SNP database from Jackson lab. It has 6,348,627 SNPs for a total 
of 87 commonly used mouse strains, including the four strains I selected. The second 
is Wellcome Trust Centre for human genetics (WCTC) SNP database, which has 
13,370 genotyped SNPs for 480 strains uniformly distributed across the mouse 
genome. The third one is NIEHS & Perlegen SNP database, with 8,322,543 SNPs in 
15 non-reference mouse strains (Frazer et al. 2007). A second set of candidate genes 
were selected from the results of a survey for novel imprinted genes in human (Pollard 
et al. 2008). In collaboration with Drs. Katie Pollard and Kelly Frazer, we did a 
genome-wide scan of expression level of paternal and maternal alleles by hybridizing 
both gDNA and cDNA to Perlegen resequencing arrays, which contain 7109 coding 
SNPs in 68 human cultured lymphoblastoid cell line samples from the CEPH panels. 
The mouse orthologs of human candidate imprinted genes from this study were also 
included in our array design. Because oligo dT primer is used in the cDNA synthesis 
step, all selected genes have at least one SNP within 800bp of 3’-UTR region. To 
make sure that there is enough expression level for selected genes in the tissues we 
used, I checked the Affymetrix Mouse Genome 430 v2.0 GeneChip array data from 
NCBI Gene Expression Omnibus published by Lindsley RC and Murphy KM (Nov. 
2004, GSE1986).  
 
Known paternally and maternally expressed imprinted genes in mouse were selected 
as positive control genes. Non-imprinted genes are needed to be chosen as negative 
control genes. There are more than 300 genes in mouse genome for which 
homozygous transgenic mutation is lethal. If such a gene is imprinted in mouse, it has 
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monoallelic expression from one parent, therefore, the heterozygous mutation 
inherited from this parent in the inbred strain background will also be lethal. I 
examined the phenotype description of all 300 genes and selected those with clear 
description that there is no observable difference between heterozygotes and wild 
types. The gene selection is summarized in (Table 1). 
 
Microarray probe design and experiment design  
To quantify the allelic expression ratios for target genes, we need to hybridize the 
cRNA to probes that could distinguish the paternal and maternal alleles. The array is 
designed as a combination of an expression array and a SNP genotyping array. I used 
25 nucleotides oligos as probes to the target sequence. The SNP position is located in 
the middle of the probe, or off by 1bp depending on the probe quality. Instead of using 
staggering probes, we decided to target multiple SNPs per gene. We will have higher 
confidence if more than one SNPs show different allelic expression signal. Because 
mismatch probes often have some signal, I included all 4 nucleotides (A, G, C and T) 
at the SNP position, with the three mismatched oligos as negative controls. The 
criteria for the probe design are as follows: the probe is 25 nucleotide long and it is 
within 3’end 800bp region; the Tm range of the probes is 62±6 °C; the maximum 
hairpin ΔG< -4 kcal/mol, and the maximum self dimer ΔG< -7 kcal/mol; the 
maximum homopolymer repeat nucleotide length ≤4. I then blasted the target 
sequence (201bp) and probe sequence against the mouse RefSeq database to make 
sure that they only have unique hit. Since we are using cRNAs for hybridization, the 
probe should be on the sense strand.  
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Table 1. Summary of gene and SNP selection for Agilent array design. 
Total 
#(genes)
Genes 
covered
SNP 
selected
600 genes list 600 274 773
Perlegen 56 31 73
Positive 96 23 81
Negative 85 48 114
Total 837 376 1041  
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For the microarray experiment design, I selected two strain combinations (AKR-PWD 
and B6-C3H) and did reciprocal crosses for these strains. In each strain combination, I 
labeled one paternal strain with Cy3 and the other with Cy5, and hybridized the cRNA 
from them to one array. I also labeled the reciprocal F1s with Cy3 and Cy5 
respectively, and hybridized them to one array. Dye swaps were included to control 
the dye effect. In total, there are 8 arrays with 1,900 probes each on a single slide 
(Figure 2 and Figure 3).  
 
Labeling and hybridization  
cDNA samples were synthesized using MMLV RT in Agilent Low RNA Input Linear 
Amplification Kit PLUS, Two-Color (Cat. No. 5188-5340). Positive and negative 
control RNA mix from Agilent RNA Spike-In Kit (Cat. No. 5188-5279) was included 
in the starting total RNA samples. Then cRNAs were synthesized from the cDNA as 
template and labeled with Cy3 or Cy5. Labeled cRNAs were purified and quantified, 
before hybridized to the Agilent microarray. The hybridization and washing conditions 
were from the manufacture’s protocols. The slide was then dried and scanned using 
GenePix 4000B scanner at 5µm resolution.  
 
Microarray data analysis 
The background subtraction of the probe intensities was done in GenePix software. 
Then I used R package smida for spatial and dye normalization. Custom R script was 
used for spike-in normalization. After normalization, overall the intensity of perfect 
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match probes is higher than the mismatch probe. Probes with a normalized intensity 
greater than 30 were defined as informative probes. The SNPs with at least 6 (out of 8) 
informative perfect match probes are classified as informative SNPs. About 40% of all 
the SNPs are informative.  
 
Pyrosequencing verifications 
Pyrosequencing primers were designed for positive control genes and the 10 candidate 
imprinted genes. PCR products for Pyrosequencing were amplified using biotin 
labeled forward (or reverse) primer. The Pyrosequencing was done on a PSQ™ 96 
MA Pyrosequencer (Biotage, AB) with the Pyro Gold Reagents (Biotage, AB). The 
relative level of the two parental alleles was quantified by the software for PSQ™ 96 
MA Pyrosequencer (Version 2.02 RC 5.8, Biotage, AB) using the allele quantification 
method. 
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Figure 2. Custom microarray experimental design.  
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Figure 3. Sample information and microarray hybridization. Sample-Cy3 is the 
cRNA sample labeled with Cy3, and Sample-Cy5 indicates the cRNA samples 
labeled with Cy5. 
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Results 
 
Identification of candidate imprinted genes from microarray data 
After normalization, the relative fold change of the allele-specific probe intensity in 
the two reciprocal F1 crosses is plotted (Figure 4). From the plot, we observed that for 
the non-imprinted negative control genes, the fold differences are less than 1.5 if the 
reference and alternative allele probes are flipped (one is greater than 1.0 and one is 
less than 1.0). If the two probes show the same direction (both are greater than 1.0 or 
both are less than 1.0), the fold change is less than 2.2 (Table 2), which is consistent 
with the fact that they are not imprinted. Based on the results of negative control 
genes, I draw an arbitrary cutoff to identify candidate imprinted genes for verification.  
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Table 2. Fold change of negative control genes. 
Probe1 Probe2
ENSMUSG00000025793 37238091 0.712  0.820  1.152 
ENSMUSG00000025793 37238095 0.698  1.029  1.474 
ENSMUSG00000028717 37697710 1.091  1.977  1.811 
ENSMUSG00000026193 47460976 0.817  0.974  0.839 
ENSMUSG00000029910 47963016 2.812  1.281  2.196 
ENSMUSG00000024909 50578926 1.935  2.849  1.473 
ENSMUSG00000019979 50888995 0.584  0.948  1.622 
ENSMUSG00000019979 50888997 1.061  0.854  1.242 
ENSMUSG00000000555 52584131 1.219  1.912  1.568 
ENSMUSG00000041324 52620099 1.748  1.777  1.016 
ENSMUSG00000055254 52641889 1.026  0.882  1.163 
ENSMUSG00000054191 60643738 1.127  1.165  0.967 
ENSMUSG00000004565 61076766 0.703  0.434  1.619 
Gene SNP_ID reciprocal F1 ratio Fold of 
difference
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Figure 4. Plot of Agilent microarray results. Plotted on the x-axis is the 
paternal/maternal expression ratio in AxB cross (A is the mother). Plotted on y-
axis is the log2 ratio of the ratio of B/A in the two reciprocal F1s. 
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Verification of positive control and candidate imprinted genes 
Two positive control genes (Meg3 and Peg5) showed clear imprinting pattern with 
fold change of 300-1800 (Table 3). Peg5 (also known as Nnat) is a known imprinted 
genes expressed only from paternal allele in mouse neonatal brain (Kagitani et al. 
1997; Kikyo et al. 1997). We correctly detected this gene as imprinted in our 
microarray. Meg3 (also known as Gtl2) is a known maternally expressed imprinted 
genes but its imprinting status in neonatal brain is not clear (Miyoshi et al. 2000; 
Schmidt et al. 2000; Takada et al. 2000). I found that Meg3 is imprinted in P2 neonatal 
brain. Pyrosequencing primers were designed for positive control genes, and both of 
them were confirmed to be imprinted (Figure 5 and Figure 6).  
 
From the 150 informative target genes on the microarray, with the arbitrary cutoff, I 
identified 10 candidate imprinted genes (Table 4). The fold of change of these genes is 
not as high as the positive control genes (Table 5). Then I used allele-specific 
pyrosequencing to verify them. Five of the candidate genes (B230120H23Rik, 
E030037J05Rik, Ednra, Prkar2b and Shrm) showed roughly equal expression from 
both parental alleles. The others showed an expression QTL effect with higher 
expression level in the AKR (or C3H) strain.  
 
We did not identify novel imprinted genes because we only tested about 150 genes 
and the bioinformatics support is relative weak. But the microarray approach worked 
perfectly and it can detect known imprinted genes. Also, pyrosequencing is an 
accurate way of quantifying allele-specific expression with 1-2% confidence interval 
of the ratio.  
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Table 3. Microarray results for the positive control genes Peg5 and Meg3.  
 
 
 
  
Probe1 Probe2
37546101 4.850  0.224  21.648  P
37546102 4.566  0.014  323.705  P
37546103 14.396  0.341  42.230  P
61717777 0.004  7.186  1847.324  M
61717778 0.094  74.708  792.774  M
Fold of 
differenc
Exp allele
Nnat 
(peg5 )
Gtl2 
(Meg3 )
Gene SNP_ID Reciprocal F1 ratios
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Figure 5. Pyrosequencing verification for mouse Peg5 in neonatal brain. 
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Figure 6. Pyrosequencing verification for mouse Meg3 in neonatal brain. 
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Table 4. List of candidate imprinted genes from custom SNP microarray study. 
 
No Gene name Fold IP status Gene description Gene Function
1 Cuzd1 3.828 M CUB and zona pellucida‐like 
domains 1
plays an essential role in trypsinogen 
activation
2 H2-Aa 4.278 P histocompatibility 2, class II 
antigen A, alpha
    major histocompatibility protein 
class II alpha chain
3 Insl5 6.656
4.615
M insulin‐like 5 is expressed in mouse brain and has a 
role in mobilization of calcium
4 E030037J05Rik 4.991 P tensin 1 Homozygous knock out mice show 
disruption of cell‐matrix junctions in 
5 B230120H23Rik 3.604 M sterile‐alpha motif and leucine 
zipper containing kinase AZK involved in MAPK signaling pathway
6 Olfr544 6.255 P olfactory receptor 544     G‐protein‐coupled receptor
7 Ednra 3.001 M endothelin receptor type A is crucial for early neural crest cell 
patterning
8 Bcl2l14 6.15 P Bcl2‐like 14 apoptosis facilitator
9 Prkar2b 21.99 M protein kinase, cAMP 
dependent regulatory, type II 
Disruption in mice causes a lean 
phenotype, nocturnal hyperactivity, 
10 Shrm 3.018 P shroom family member 3 facilitates neural tube closure by 
regulating cell shape changes 
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Table 5. Fold of change of candidate imprinted genes in the microarray study. 
 
Probe1 Probe2
Cuzd1 50472329 0.733  2.806  3.828  AKR x PWD
H2‐Aa 62694722 3.218  0.752  4.278  AKR x PWD
Insl5 38306343 0.552  3.675  6.656  AKR x PWD
Insl5 38306346 0.284  1.184  4.165  B6 x C3H
B230120H23Rik 38119858 0.702  2.531  3.604  AKR x PWD
E030037J05Rik 51276876 2.294  0.460  4.991  AKR x PWD
Olfr544 61044690 6.031  0.964  6.255  AKR x PWD
Ednra 60637726 0.716  2.147  3.001  AKR x PWD
Prkar2b 61590861 0.661  14.548  21.994  B6 x C3H
Shrm 46606289 1.124  0.372  3.018  B6 x C3H
Bcl2l14 60950825 3.202  0.521  6.150  B6 x C3H
Gene SNP_ID Reciprocal F1 ratios Fold of 
difference
Strain 
combination
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Discussion 
 
Custom microarray for detecting allele-specific expression 
In this study, I designed a custom microarray to use for combined expression analysis 
and SNP genotyping. The imprinted status of the known imprinted genes and non-
imprinted genes was correctly identified from the array results. Therefore, the allele-
specific microarray method is valid for detecting allelic expression ratios. However, 
there are several limitations for the array method. Some mismatch probes have 
substantial signal intensity, making a large fraction of the probes uninformative. There 
are computational methods to predict the affinity of perfect match probes, but they 
cannot predict the affinity difference between the perfect match and mismatch probes. 
In addition, the microarray can only include known gene models, so it cannot query all 
transcripts and different splice variants in the transcriptome.  
 
Computational prediction for novel imprinted genes 
Here, to discover novel imprinted genes in mouse and test the imprinting status of 
their human orthologs, I chose two mouse strain pairs (AKR x PWD, B6 x C3H) and 
extracted total RNA from post-natal day 2 brain of both parents and the reciprocal F1s. 
156 genes were selected as candidate genes from 600 putative mouse imprinted genes 
predicted by Luedi et al. (2005). Additional candidates were selected among orthologs 
of 63 potentially imprinted genes in humans (identified by uniparental expression in 
collaboration with Perlegen Sciences). Then I designed 25-mer oligo probes for a total 
of 396 exonic SNPs in the test genes and had a microarray printed by Agilent.  By 
hybridizing the Cy3 and Cy5 labeled cRNAs made from the RNA samples to this 
microarray, we were able to tell the relative abundance of the two SNP alleles in the 
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two reciprocal F1 strains. By applying an arbitrary cutoff, I found 10 candidate 
imprinted genes, but allele-specific pyrosequencing could verify none of them.  
 
Computational prediction methods, including machine learning approaches, are very 
powerful for predicting functional elements and transcription factor binding sites in 
genomes. However, the prerequisite for successful prediction is sufficient and correct 
training data. The computational predictions for novel imprinted genes using DNA 
sequence related data suffer from the following limitations. First, there are very 
limited known imprinted clusters serving as training data. There are about 100 known 
imprinted genes in human and mouse, but they are not independent. Instead, they 
arrange in only 20 clusters. If you use 10 clusters as the training data and the other 10 
as the verification set, the lack of data will result in an over-fitting problem in 
statistical learning, causing high false positive rate. Second, the tissue and 
developmental-stage specificity of genomic imprinting was ignored for prediction. 
Among the 100 known imprinted genes, for a specific tissue and developmental stage, 
only a subset of them is imprinted. The prediction method ignored this, and it does not 
know which tissues and stages are appropriate for verification of the candidates. Third, 
there are maternally and paternally expressed genes. Classifying the training set to 
these two directions further reduces the training data, causing more severe over-fitting. 
In most of the cases, the paternally and maternally expressed imprinted genes are 
present in the same imprinting cluster. Fourth, some imprinted genes show preferential 
maternal/paternal expression. The degree of imprinting for partial imprinted genes was 
ignored. Fifth, within a single imprinting cluster, there are multiple transcribed genes, 
but not all of them are imprinted. Some of them are imprinted but the others show 
biallelic expression. It is extremely difficult to distinguish such genes in the same 
cluster by DNA sequence related features. Sixth, because there are only 20 imprinting 
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clusters, for the non-imprinted control gene selected, there are many different genes 
(all other genes in the genome) to choose from. In 2005, there were not many studies 
for a list of confirmed non-imprinted genes, therefore the selected non-imprinted 
genes could be imprinted or partially imprinted. To solve the problem in my previous 
point, non-imprinted genes in an imprinting cluster were not selected in the training 
set. The bias in selection of non-imprinted control genes will also cause over-fitting 
and high false positive rate. Seventh, the mechanism of genomic imprinting is not 
fully understood yet. The pattern discovered from the training data could only identity 
novel imprinted genes with the same mechanisms. Some potential imprinted genes 
with unknown mechanisms will be missed. Last but not least, in the machine learning 
approach, more than 7000 different features were used for predicting the imprinting 
status. Using such a large number of features will likely increase the possibility of 
over-fitting. Our microarray study did not confirm any of the prediction imprinted 
genes in mouse brain. Daelemans et al. (2010) performed a similar allele-specific 
microarray study targeting 932 genes in human term placenta (Daelemans et al. 2010). 
Their array design is enriched for the 124 predicted imprinted genes in human (Luedi 
et al. 2007), and none of them were confirmed either.  
 
Will using epigenetic marks improve the computational prediction for novel 
imprinted genes?  
Genomic imprinting is an epigenetic phenomenon, so using only DNA related features 
is not sufficient. I think including data from the epigenetic marks such as DNA 
methylation pattern and different histone modifications will increase the power, 
because you are adding more tissue-specific predictors. However, the epigenetics 
marks are dynamic during development, and are highly tissues-specific. Therefore, to 
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get correct results, all epigenetics marks used in the computational prediction must be 
from the same tissue. Also, the predicted candidate genes should also be verified in 
this tissue. Including epigenetics marks from a variety of different cell lines at 
different developmental stages would not help much in terms of predicting power.  
 
 
The path to a complete list of imprinted genes in the genome  
The ultimate goal is to understand the evolutionary constraints imposed by the 
effective loss of diploidy engendered by genomic imprinting. Developing a more 
complete list of imprinted genes will help fully test ideas about genomic conflict. 
Bioinformatic prediction has its own limitations due to lack of training data and the 
over-fitting problem. We would like to develop a novel method that could query the 
imprinted status of all transcribed genes in the genome.  
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CHAPTER 2  
Identification of novel imprinted genes in mouse neonatal brain from RNA-seq 
data1 
Abstract 
Imprinted genes display differential allelic expression in a manner that depends on the 
sex of the transmitting parent. The degree of imprinting is often tissue-specific and/or 
developmental stage-specific, and may be altered in some diseases including cancer. 
Here we applied Illumina sequencing of the transcriptomes of reciprocal F1 mouse 
neonatal brains and identified 26 genes with parent-of-origin dependent differential 
allelic expression. Allele-specific Pyrosequencing verified 17 of them, including three 
novel imprinted genes. The known and novel imprinted genes all are found in 
proximity to previously reported differentially methylated regions (DMRs). Ten genes 
known to be imprinted in placenta had sufficient expression levels to attain a read 
depth that provided statistical power to detect imprinting, and yet all were consistent 
with non-imprinting in our transcript count data for neonatal brain. Three closely 
linked and reciprocally imprinted gene pairs were also discovered, and their pattern of 
expression suggests transcriptional interference. Despite the coverage of more than 
5000 genes, this scan only identified three novel imprinted RefSeq genes in neonatal 
brain, suggesting that this tissue is nearly exhaustively characterized.  This approach 
has the potential to yield a complete catalog of imprinted genes after application to 
multiple tissues and developmental stages, shedding light on the mechanism, 
bioinformatic prediction, and evolution of imprinted genes and diseases associated 
with genomic imprinting. 
                                                 
1 This study was published in Wang X, Sun Q, McGrath SD, Mardis ER, Soloway PD, Clark AG., 
2008. Transcriptome-wide identification of novel imprinted genes in neonatal mouse brain. PLoS One, 
3(12):e3839. 
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Introduction 
 
To date, 98 genes have been shown to undergo genomic imprinting in mouse, and 56 
genes are imprinted in humans, with an overlapping set of 38 genes imprinted in both 
species (Morison et al. 2005). For neither species is the list of imprinted genes 
complete. Genome-wide bioinformatic predictions face the challenge of a high false 
positive rate, mostly because the training set of known imprinted genes is small, and 
we do not know all the signals driving tissue- and time-specificity of imprinting 
(Luedi et al. 2005; Luedi et al. 2007). Attempts at exhaustive scans for imprinted 
genes in humans have encountered several drawbacks, including the challenge of 
using the most appropriate tissue and developmental stage, a problem exacerbated by 
reliance on lymphoblastoid cell lines (LCLs) (Pollard et al. 2008).  Many imprinted 
genes show tissue- and developmental stage-specific expression, and many are 
expressed and imprinted only in specific stages of brain development. Human studies 
also face the challenge of a low number of informative heterozygous SNPs, so that 
allele-specific assays are useful for only a small subset of individuals. Hence, pedigree 
information is needed to distinguish genomic imprinting from stochastic monoallelic 
expression (Lomvardas et al. 2006; Gimelbrant et al. 2007). These factors greatly 
amplify the effort and cost needed for a transcriptome-wide scan for imprinted genes 
in humans. By contrast, large-scale mouse studies have used uniparental disomy 
(Cattanach and Kirk 1985; Ferguson-Smith et al. 1991; Cattanach et al. 1992; Schulz 
et al. 2006; Ogata et al. 2008; Yamazawa et al. 2008) to detect parent-of-origin effects. 
While this approach has led to the discovery of many imprinted genes, and to the 
refinement of phenotypic analysis of the consequences of disruptions in imprinting, 
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not all genomic regions are covered by uniparental disomies, and there is a risk that 
such aberrant genome configurations may distort expression patterns. Microarray-
based approaches using allele-specific probes can only detect nearly “all-or-none” 
imprinting with confidence, because quantitative differences between maternal vs. 
paternal allelic expression have high error due to the cross hybridization of the perfect-
match and mismatch probes (Bjornsson et al. 2008; Serre et al. 2008). In fact, genomic 
imprinting may occur as a continuum from complete uniparental expression to a slight 
but significant bias in the parental allele that is expressed, and a technology that could 
reliably detect quantitative differences in allele-specific expression at a transcriptome 
scale would greatly accelerate imprinting research. 
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Materials and Methods 
 
Mouse Strains 
Please see Chapter 1 for the mouse strains information and the method for total RNA 
extraction.   
 
Illumina sequencing of the transcriptome 
 
One Illumina Genome Analyzer run was performed for each reciprocal F1 of PWD 
and AKR mice at the Genome Center at Washington University. cDNA was 
synthesized using a modified version of the SMART Technology (ClonTech). To 
improve sequence coverage, we used a size selection procedure that removed cDNAs 
shorter than 1.3 kb in length. One Illumina Genome Analyzer run of each reciprocal 
F1 sample was run on the Illumina Genome Analyzer.  
 
Synopsis. Mouse total RNA was converted to first strand cDNA using a modified-
SMART protocol. The first strand cDNA was then PCR amplified and size 
fractionated in 6% polyethylene glycol (PEG)/0.55M sodium chloride (NaCl) to enrich 
for cDNA ≤1250bp.  SMART adapters were then excised from the cDNAs using 
MmeI and the adapters were removed from the reaction using 11% PEG/0.5M NaCl. 
The purified cDNA population then was fragmented and used as the source for a 
standard Illumina fragment library. 
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Modified-SMART.  First strand cDNA was produced from mouse total RNA 
according to a modified version of the Clontech SMART protocol (E. Mardis, 
personal communication), using approximately 1 µg of total RNA and SuperScript II 
(Invitrogen).  
 
Cycle optimization PCR and production PCR.  The modified-SMART cDNA was 
used as the template in a PCR reaction to determine the number of cycles at which the 
reaction is no longer exponential.  The cycle optimization reaction used 1 µl of the 
first strand cDNA reaction.  Aliquots were removed at 2 cycle timepoints between 16 
and 24 cycles.  They were then run on a Flashgel (Lonza) for 5 min at 275 v, and the 
optimum cycle number was determined by observation. 
 
The production PCR consisted of eight 100 µl reactions identical in composition to the 
cycle optimization reaction except that 2 µl of first-strand cDNA was used for each 
reaction and the empirically determined cycle optimum number was used for 
amplification of all eight reactions. The PCR products were purified and concentrated 
with two Qiaquick columns (Qiagen), according to the manufacturer’s protocol, and 
eluted with 30 µl Buffer EB (Qiagen) per column. 
 
Size fractionation.  To fractionate cDNA ≤1250 bp, the amplified cDNA from the 
production PCR reactions was resuspended in a 300 µl reaction of 6% PEG-8000, 0.55 
M NaCl and carboxylate paramagnetic beads.  The mixture was vigorously vortexed 
and incubated for 10 min at room temperature.  The reaction was placed on a 
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magnetic particle collector (MPC, Invitrogen) for two min and the supernatant, 
containing the ≤ 1250 bp fraction, was transferred to a clean tube. This cDNA fraction 
was purified over a Qiaquick column according to the manufacturer’s protocol, and 
eluted in 50 µl Buffer EB. 
 
Adapter removal and cDNA purification.  The 5’ and 3’ adapters added during 
cDNA synthesis, contain MmeI recognition sequences that are removed by digestion 
in a 100 µl reaction containing 1x NEB Buffer 4 (20 mM Tris-acetate, 
50 mM potassium acetate, 10 mM magnesium acetate, 1 mM dithiothreitol, pH 7.9 @ 
25°C), 10 µg of 10mg/ml BSA, 64 µM S-adenosylmethionine (New England Biolabs) 
and 12 units MmeI (New England Biolabs) for 30 min at 37°C.  The digested cDNA 
was purified and concentrated with 1 Qiaquick column according to the 
manufacturer’s protocol, and eluted with 30 µl Buffer EB. 
 
A second round of PEG/NaCl fractionation further removes the adapter fragments 
released by Mme1 digestion. Here, the cDNAs purified by Qiaquick column were 
resuspended in a 300 µl reaction of 11% PEG-8000, 0.5M NaCl and carboxylate 
paramagnetic beads.  The mixture was vigorously vortexed and incubated for 10 min 
at room temperature.  The reaction was placed on an MPC for two min and the 
supernatant was then discarded.  The paramagnetic beads were washed twice with 
70% ethanol and air dried.  The tube containing the paramagnetic beads was removed 
from the MPC and the beads were resuspended in 50 µl Buffer EB with vigorous 
vortexing.  The reaction was placed on the MPC for two min and the supernatant was 
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transferred to a clean tube.  This fraction contains cDNA >150 bp and free of 5’ & 3’ 
adapters. 
 
Nebulization/Covaris shearing and Illumina/Illumina library prep. Sample B17 
(PWD/PhJ x AKR/J): The cDNA was sheared by nebulization (2 min at 50 PSI) and 
the sheared DNA was purified/concentrated with a single Qiaquick column according 
to the manufacturer’s protocol. Sample B21 (AKR/J x PWD/PhJ): The cDNA was 
sheared with the Covaris S2 System in 75% glycerol with the following program: 10 
cycles of 4 treatments, 60 sec each; Duty cycle = 20%; intensity = 10; 1000 
cycles/burst.  The cDNA was purified/concentrated by ethanol precipitation. 
 
The sheared cDNAs were then prepared for Illumina sequencing according to the 
manufacturer’s protocols.  Libraries were prepared from a 150-200 bp size-selected 
fraction following adapter ligation and agarose gel separation. The libraries were 
sequenced using a single end read protocol with 32 bp of data collected per run on the 
Illumina Genome Analyzer.  Data analysis and base calling were performed by the 
Illumina instrument software. 
 
Illumina sequence data analysis 
We obtained 33,519,739 reads (1072.63 Mbp total) from the PWD/PhJ x AKR/J cross 
(PWD x AKR for short) in seven lanes, and 35,510,887 reads (1136.35 Mbp total) in 
eight lanes for the reciprocal cross, AKR/J x PWD/PhJ (AKR x PWD for short).  
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Both runs have high sequence quality with 95% of the bases passing Q20 (Figure 
S1.1).   
We used a local version of the NCBI BLAST program 
(http://www.ncbi.nlm.nih.gov/blast/Blast.cgi) to align the 32-bp reads to the mouse 
RefSeq database (http://www.ncbi.nlm.nih.gov/RefSeq/). The parameters for the 
blastn program were optimized for short reads and our purpose. We did the BLAST 
jobs on 180 nodes of the CBSU clusters (http://cbsuapps.tc.cornell.edu/index.aspx) 
using the P-BLAST utility. 23.82% of the total reads in the PWR x AKR cross were 
aligned to the RefSeq database with 3.57 hits/read. 31.18% of the total reads in the 
AKR x PWD cross were aligned to the RefSeq database with 3.02 hits/read (Table 6). 
High quality SNP-containing reads were filtered out, with unique match to the RefSeq 
gene (or different transcripts of the same Entrez gene). Relative expression level of the 
two parental alleles was estimated by the relative counts of Illumina reads at the SNP 
positions in the Perlegen mouse SNP database. 59 out of the 98 known imprinted 
genes in mouse are in the mouse RefSeq database. We assembled them into ace files 
according to the BLAST alignment information. 20 novel SNPs were called in 12 
known imprinted genes from the Illumina assembly (Table 7).  
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Table 6.  Summary of BLASTN results. 
Cross Lane Total reads Matched reads
% of 
match No match Poly A/N* Total hits hits/read
s1 4,619,970 1,202,604 26.03% 3,409,387 7,979 4,369,063 3.63
s2 4,295,871 1,200,111 24.73% 3,088,792 6,968 4,408,399 3.67
s3 4,722,842 1,095,349 23.19% 3,615,132 12,361 3,852,524 3.52
s4 4,853,113 1,126,465 23.21% 3,713,847 12,801 4,009,494 3.56
s6 5,158,778 1,193,386 23.13% 3,953,819 11,573 4,249,988 3.56
s7 5,053,146 1,173,701 23.23% 3,868,074 11,371 4,178,607 3.56
s8 4,816,019 1,116,624 23.19% 3,688,339 11,056 3,919,609 3.51
s1 4,096,916 1,241,763 30.31% 2,777,901 77,252 3,749,816 3.02
s2 4,339,623 1,322,613 30.48% 2,922,408 94,602 3,996,721 3.02
s3 4,447,068 1,361,104 30.61% 2,990,873 95,091 4,126,160 3.03
s4 4,397,822 1,348,417 30.66% 2,956,351 93,054 4,073,444 3.02
s5 4,399,210 1,369,262 31.13% 2,932,067 97,881 4,150,208 3.03
s6 4,509,790 1,417,377 31.43% 2,992,308 100,105 4,289,787 3.03
s7 4,493,249 1,444,386 32.15% 2,946,392 102,471 4,345,896 3.01
s8 4,827,209 1,576,487 32.66% 3,140,904 109,818 4,746,400 3.01
*: low complexity reads including polyA and polyT
PWD x 
AKR
AKR x 
PWD
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Table 7. Known imprinted genes covered by assembly of Illumina reads. 
AKR 
count
PWD 
count
AKR 
count
PWD 
count
NM_011245 16 0 0 20 Rasgrf1 chr9 4243
NR_002864 168 0 6 74 Peg13 chr15 4745
XR_035484 1 339 193 1 Gtl2 chr12 1890
NM_001077507 181 214 101 96 Gnas chr2 3733
NM_001033962 3 10 4 2 Ube3a chr7 4910
NM_010514 52 43 20 27 Igf2 chr7 4038
NM_008672 9 12 61 76 Nap1l4 chr7 2283
NM_009876 0 8 13 0 Cdkn1c chr7 1849
NM_010345 2 3 6 10 Grb10 chr11 5015
NM_021432 22 0 0 67 Nap1l5 chr6 1909
NM_181595 36 54 67 26 Ppp1r9a chr6 9547
NR_001592 2 14 61 1 H19 chr7 2615
RefSeq_lenRefSeq_ID
PWD x AKR AKR x PWD
Gene_name Chr
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Estimation of the relative parental expression 
To identify the SNP positions in the mouse RefSeq database, we used the SNP 
genotype and information in the Perlegen mouse SNP database 
(http://mouse.perlegen.com). Perlegen Sciences and NIEHS genotyped 8 million SNPs 
among 15 mouse strains with a genome coverage of 70%, including PWD and AKR. 
The SNP density is approximately 3 SNPs/kb and most of the genic regions are 
covered in the database. The genome coordinates of the reviewed and validated mouse 
RefSeq sequences (starting with NM and NR, see 
http://www.ncbi.nlm.nih.gov/RefSeq/key.html#status) were downloaded from the 
UCSC genome browser (www.genome.ucsc.edu, July 2007 assembly). The SNP 
positions in the RefSeq sequences were filtered by the RefSeq gene coordinates. To 
correct for gaps in the RefSeq-genomic sequence alignments, we also did text matches 
using 20 bp upstream and downstream the SNP positions. A total of 206,589 Perlegen 
SNPs were found in 18,797 RefSeq sequences (Table 8 andTable 9), with an average 
SNP density of 11 SNPs/RefSeq sequence (Figure 7). 4,127 SNPs with missing data in 
the Perlegen SNP database were called based on the Illumina sequence reads. The 
genotypes of all the high quality Perlegen SNPs (q-score ≥ 10, Mismatch ≤ 4 for 
alternative allele, Mismatch ≤ 3 for reference allele and match length ≥ 28) covered in 
the Illumina reads were summarized in the two reciprocal F1s. 175,687 (84.71%) of 
the 207,407 Perlegen RefSeq SNPs were not covered or not informative (less than 1 
SNP count in both direction). In the 31,720 Illumina-covered Perlegen SNPs, 25,289 
(83.21%) were confirmed by Illumina reads, and 4,127 (13.58%) Perlgen SNPs with 
missing data (N) in AKR and PWD strains were called based on the Illumina sequence 
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information (Figure 8). The newly called SNPs were included in the data analysis. 
From the results, the genotype of the Illumina short-read sequence identified SNPs are 
consistent with the Perlegen SNP, indicating high sequence quality of our Illumina 
Genome Analyzer run. There are only 161 inconsistent SNPs, most of which are the 
complementary allele and could come from the antisense transcript of the RefSeq 
gene. 
 
The expression level of the RefSeq transcripts were quantified by the number of 
perfectly matched reads in the Illumina sequence data. 15,491 RefSeq genes were 
covered by at least one perfect match read in each of the two reciprocal crosses 
(Figure 9). 
 
In order to do the quality control and filter out the true SNP-containing reads, several 
criteria were considered. The Illumina sequence SNPs (Perlegen SNP that are present 
in our Illumina reads) were classified to six categories according to their consistency 
with the Perlegen SNP information (Figure 10). Classes 1-5 are the consistent SNPs. 
Class 1 includes SNPs that are polymorphic between AKR and PWD strains. These 
are the SNPs we want to use in our study to quantify the relative parental expression. 
Class 2 SNPs are also consistent but the SNP is not polymorphic between AKR and 
PWD strains. Classes 3-5 are SNPs that have missing data (N) in the Perlegen 
database. The rest of the Illumina SNPs are classified in class 0, which are the 
inconsistent SNPs. Most of the Illumina SNPs have a quality score 20 or above 
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(Figure 10). The distribution of the number of mismatches showed that the pattern 
class 1 SNPs are consistent with perfectly matched reference and alternative alleles, an 
attribute not seen in any other SNP classes (Figure 11). So the class 1 SNPs were used 
in the following analysis. Regarding the match length of the SNP-containing reads, 
more than 80% have a full length match (32 bp), and most of the reads have a match 
length of 25 or more. The blastn algorithm is a local alignment algorithm, so if there 
are SNPs in the first or last 2 bp of a read, the alignment will be truncated, although it 
is still considered a full length match (Figure 12). Two sets of filter criteria were used 
before the final SNP counts for each RefSeq gene were summarized (Table 10). Both 
Filter 1 and Filter 2 are conservative and the reads after the filtering all matched 
uniquely to the Entrez gene database (could be more than one RefSeqs due to 
alternative splicing).  Since there is no lane effect, the AKR and PWD counts in the 
two reciprocal crosses are summarized by RefSeq genes and by SNPs. 326 class 1 
SNPs are not polymorphic in the Illumina sequence data due to the repetitive match of 
the SNP-containing sequence in the mouse genome, so we do not know where 
transcripts bearing these SNPs are coming from. Such SNPs are excluded from the 
final analysis. 
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Table 8. Categories of Perlegen SNP in the RefSeq sequences. 
Categories Coordinates filter
Text 
match Status
# of RefSeq 
sequences % Total
Conisistent YES YES Consistent 172,104 83.31%
Corrected by text 
match * YES YES
Inconsistent, corrected 
by text match 15,679 7.59%
Coordinates 
information only ** YES NO Coordinates only 18,806 9.10%
Total 206,589
*: There are discrepency between the RefSeq and genomic sequence alignment. The 
gaps in the alignment could be corrected by the text match. 
**: Not all coordinate filtered SNPs have text match results, because of the exon-intron 
boundary problem.
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Table 9. Consistency of Perlegen SNP alleles and the RefSeq alleles. 
RefSeq P_reference P_alternative
 RefSeq allele is conisistent with 
Perlegen reference allele A A C 202,718 98.13%
 RefSeq allele is conisistent with 
Perlegen alternative allele * A C A 3,829 1.85%
 RefSeq allele is NOT 
conisistent with Perlegen alleles 
**
A G T 42 0.02%
Total 206,589
**: The inconsistent SNPs could be due to Perlegen genotyping error, RefSeq 
sequencing error or RNA editing.
Categories
Example
Counts % of Total
*: The Perlegen reference allele is from the reference genome sequence, which is 
C57BL/6. Not all the RefSeq sequences come from the C57BL/6 strain whose genome 
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Figure 7. Distribution of number of Perlegen SNPs per RefSeq genes. 
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Figure 8. SNP calling for the Perlegen missing data.  
(A). Summary of coverage of the Perlegen RefSeq SNPs. Informative: SNP 
counts >= 1 in both the two reciprocal crosses. (B). Summary of the Illumina 
Informative SNPs. Confirmed: Perlegen SNPs that present in Illumina and the 
genotypes agree with each other. Called: Perlegen SNPs with missing data in 
AKR and PWD that called based on the Illumina information. 
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Figure 9. Coverage distribution in the Illumina data. Histogram of number of 
perfect match reads per gene for 15,491 RefSeq genes covered by at least 
one perfect match read in each of the two reciprocal crosses. (Only RefSeq 
genes with 10,000 or less perfect match reads are shown. There are 124 
genes with number of perfect match reads > 10,000.) 
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Table 10. Criteria for SNP filtering of the Illumina data. 
Filter 1
• Type 1 SNP only. 
• Q-score of the SNP position >= 10 
• Mismatch score for reads containing reference allele: 3 
• Mismatch score for reads containing alternative allele: 4 
Filter 2
• Type 1 SNP only. 
• Q-score of the SNP position >= 10 
• SNP within 1.3kb to the 3’-end. 
• Mismatch score for reads containing reference allele: 3 
• Mismatch score for reads containing alternative allele: 4 
• Match length >= 28. 
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Figure 10. Quality score distribution of Illumina SNPs by SNP class. Shown 
here is lane 1 for PWD x AKR cross. 
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Figure 11. Mismatch score distribution of Illumina SNPs by SNP class. Shown 
here is lane 1 from PWD x AKR cross.  
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Figure 12. BLASTN match length distribution of Illumina SNPs by SNP class. 
Shown here is lane 1 from PWD x AKR cross. 
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Detecting genomic imprinting and Statistical analysis 
We have the filtered AKR and PWD allele counts for the two reciprocal F1s. We 
define p1 as the AKR allele proportion in the PWD x AKR cross and p2 as the AKR 
allele proportion in the AKR x PWD cross (Table 11).  If a gene has equal expression 
from the two parental alleles, p1 and p2 will be approximately 0.5.  If a gene is an 
expression QTL (eQTL) with higher expression from the AKR-derived allele, p1 will 
be approximately equal to p2 and both p1 and p2 will be greater than 0.5. A paternally 
expressed imprinted gene will have the pattern of p1 > 0.5 and p2 < 0.5, whereas a 
maternally expressed imprinted gene will have the pattern of p1 < 0.5 and p2 > 0.5 
(Table 12). The advantage of having the reciprocal crosses is that we could distinguish 
an eQTL from true genomic imprinting.  
 
A formal statistical test is needed to test the significance. We did not use Fisher’s 
exact test because it is a conservative test and results in substantial loss of power, 
especially when the total counts are small (Lehmann and Romano 2005). Rather, we 
used a modern statistical method, the Storer-Kim method for two independent 
binomials to test whether there is a significant difference between the two binomial 
parameters, p1 and p2 (Storer and Kim 1990). The P-values were calculated using 
Wilcox’s code (Wilcox 2003) in R (version 2.60, www.r-project.org). The 95% 
confidence intervals for p1 and p2 were also obtained by the Wilson method (Wilson 
1927) (R, the binom package). False discovery rate (q-value) was calculated by the 
qvalue package in R (Storey et al. 2004).  
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Table 11. Definition of p1 and p2. 
Cross AKR allele counts
PWD allele 
counts
PWD x AKR a b p1 = a/(a+b)
AKR x PWD c d p2 = c/(c+d)
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Table 12. Detecting genomic imprinting. 
p1 = p2 = 0.5 Relatively equal expression from the two parental copies.
p1 = p2 > 0.5 eQTL with higher expression from the AKR strain
p1 = p2 < 0.5 eQTL with higher expression from the PWD strain
p1 != p2, p1 > 0.5, p2 < 0.5 Paternally expressed imprinted candidate gene
p1 != p2, p1 < 0.5, p2 > 0.5 Maternally expressed imprinted candidate gene
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Sanger and Pyrosequencing verification 
We designed Pyrosequencing PCR and sequencing primers for the candidate 
imprinted genes using Pyrosequencing Assay Design Software Version 1.0.6 (Biotage 
AB). To guarantee that there are no SNPs within the primers, SNP positions in the 
Perlegen database were labeled and excluded when designing the primers. PCR 
amplification for Pyrosequencing was done using TaqGold Enzyme (Applied 
Biosystems) with a 45 cycles of 3-step PCR (95°C for 45s, 46-58°C for 30s and 72°C 
for 10-20s) followed by a final extension of 10 min. The PCR products (80-300 bp) 
were purified by Exonuclease I and Shrimp Alkaline Phosphatase and sequenced 
bidirectionally using the original Pyro PCR primers on ABI 3730xl DNA analyzer 
(Applied Biosystems) with BigDye Terminator v3.1. The sequence chromatograms 
were analyzed with CodonCode Aligner version 2.0.4 (CodonCode Corporation 
Software for DNA Sequencing). PCR products for Pyrosequencing were amplified 
using the same condition with biotin labeled forward (or reverse) primer. The 
Pyrosequencing was done on a PSQ™ 96 MA Pyrosequencer (Biotage, AB) with the 
Pyro Gold Reagents (Biotage, AB). The relative level of the two parental alleles was 
quantified by the software for PSQ™ 96 MA Pyrosequencer (Version 2.02 RC 5.8, 
Biotage, AB) using the allele quantification method. 
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Results 
Illumina sequencing results and SNP coverage 
Short-read sequencing (e.g. Illumina sequencing) of transcripts provides many 
advantages in imprinting studies by providing a large number of sequence tags that 
allow simple counting of transcripts encoded by the two transmitted parental alleles.  
In this study, we performed quantitative assessments of genomic imprinting in 
transcripts from reciprocal cross progeny of the AKR/J and PWD/PhJ mouse strains. 
Total RNA was extracted from postnatal day 2 (P2) F1 female mouse whole brains. 
One run of Illumina sequencing was done for each F1 female brain cDNA sample. We 
obtained 1072.63 Mbp of sequence data from the PWD x AKR cross (listing female 
strain first) and 1136.35 Mbp from AKR x PWD in 32 bp reads with high quality 
(Figure 13). On average, 27.74% of the reads were aligned to the NCBI RefSeq mouse 
genome database.  Sequence heterogeneity between alleles was great enough to 
produce poor performance by ELAND in mapping reads to the genome, so this mapping 
was performed with the NCBI BLAST program (Table 6). Altogether, 33,519,739 and 
35,510,887 reads were aligned to the RefSeq database in the respective reciprocal 
crosses. The sequences covered 15,491 RefSeq genes with at least one perfectly 
matching Illumina read in each of the two reciprocal crosses. Within these genes, we 
identified 814,360 and 884,828 reads spanning Perlegen SNPs for the two respective 
reciprocal crosses (Frazer et al. 2007). After quality control filtering (Table 10), 
320,804 and 327,451 high quality SNP-containing reads remained, allowing 
identification of parent-of-origin of each read (see Methods for more details). 5,533 
RefSeq genes (5,076 unique Entrez genes) were covered in our study with a total SNP 
count of four or more in both reciprocal crosses (Table 13). From the mouse Brain 
EST Database, among the 5,500 cDNA clones of polyA-containing 3’-end EST 
sequences in P4 cerebellum, 3,500 are distinct species (Matoba et al. 2000). This 
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contrasts with a recent SAGE study of P30 mouse brain, where the number of matched 
GenBank transcripts with copy number five or more per cell was 4,161 (Chrast et al. 
2000), but those data lacked the allele-specific identification.  Based on this 
information, we could query the imprinting status of nearly all currently known 
transcribed genes with detectable expression in mouse neonatal brain with an 
informative number of counts.   
 
Detecting genomic imprinting 
The relative expression level of the two parental alleles was quantified from the counts 
of the AKR and PWD SNP alleles in the Illumina read data (Figure 14). We define p1 
to be the percentage of counts from AKR allele in PWD x AKR cross, and p2 as the 
percentage of counts from AKR allele in AKR x PWD cross (Table 11). We identify a 
gene as a paternally expressed candidate imprinted gene if p1 is significantly different 
from p2 and where p1>0.5 and p2<0.5 (and, for maternally expressed genes, p1<0.5, 
and p2>0.5) (Table 12). The Storer-Kim test for two independent binomials (Storer 
and Kim 1990; Wilcox 2003) was used to test the significance of the difference 
between the two binomial parameters, p1 and p2, for each gene covered in the study 
(Storer and Kim 1990). q-values for each gene were calculated, and a false discovery 
rate cutoff of 0.05 was applied (Storey et al. 2004). Using these criteria, we identified 
13 paternally and 13 maternally expressed candidate imprinted genes with p1>0.65, 
p2<0.35 (p1<0.65, p2>0.35 for maternal genes) and q-value < 0.05, respectively (Table 
14). 
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Table 13. Summary of gene coverage and total SNP counts after filtering. 
RefSeq genes Entrez gene AKR* PWD** AKR* PWD**
Filter 1 5,533 5,076 175,560 (54.73%)
145,244
(45.27%)
174,300
(53.23%)
153,151
(46.77%)
Filter 2 4,467 4,116 145,778(54.47%)
121,853
(45.53%)
133,507
(52.44%)
121,096
(47.56%)
*: Total counts of AKR alleles
**: Total counts of PWD alleles
***: Genes covered by a total count of 4 or more in both cross
Filter
Gene Coverage*** PWD x AKR AKR x PWD
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Figure 13. Quality score distribution for the Illumina sequencing reads. Shown 
here is lane 1 for PWD x AKR cross. The orange bar is the average quality 
score for the first 25bp. The red bar represents the average quality score for 
all positions. 
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Table 14. Candidate imprinted genes identified by biased allelic counts among 
transcripts. 
AKR* PWD* AKR* PWD* p1 p2 p1 p2
Nnat 1 1182 1 21 1853 0 99.90% 1.10% IP IP 4 100.00% 0.00%
Snrpn 2 898 1 1 19 0 99.90% 5.00% IP IP 1 100.00% 0.00%
Snurf 2 888 1 1 18 0 99.90% 5.30% IP IP 1 100.00% 0.00%
Peg13 3 168 0 6 74 0 100.00% 7.50% NR IP 3 98.80% 3.00%
Nap1l5 3 22 0 0 67 1.20E-19 100.00% 0.00% NR IP 1 100.00% 0.00%
Inpp5f_v2 4 41 3 14 80 1.40E-17 93.20% 14.90% IP IP 2 91.90% 7.80%
Sgce 5 9 0 0 54 2.00E-09 100.00% 0.00% NR IP 2 100.00% 1.50%
Rasgrf1 6 16 0 0 20 7.50E-09 100.00% 0.00% IP IP 3 100.00% 0.00%
Impact 7 15 6 8 83 1.20E-06 71.40% 8.80% NR IP 2 79.10% 19.80%
Zrsr1 8 11 0 1 14 6.70E-05 100.00% 6.70% IP IP 0 97.50% 0.40%
Gtl2 9 1 339 193 1 0 0.30% 99.50% NR IP 4 0.00% 100.00%
H19 10 2 14 61 1 5.80E-10 12.50% 98.40% NR IP 3 9.40% 100.00%
Cdkn1c 11 0 8 13 0 1.30E-04 0.00% ####### NR IP 1 3.60% 100.00%
Commd1 12 12 33 22 7 2.60E-03 26.70% 75.90% IP IP 0 41.20% 72.50%
AKR* PWD* AKR* PWD* p1 p2 p1 p2
Inpp5f 359 19 89 1293 0 95.00% 6.40% - IP 7 83.20% 19.10%
2410042D21Rik 21 7 16 32 0.024 75.00% 33.30% - eQTL$ 0 79.90% 83.60%
BC043301 8 0 3 9 0.042 100.00% 25.00% - eQTL 0 - -
1810044A24Rik 7 20 25 5 1.10E-03 25.90% 83.30% - IP 1 20.60% 73.50%
Gyg 9 35 21 9 0.002 20.50% 70.00% - eQTL 1 40.90% 36.10%
Ppfia2 6 16 32 8 0.003 27.30% 80.00% - eQTL 0 - -
Prim1 6 81 5 2 0.005 6.90% 71.40% - eQTL 1 - -
Asns 24 60 27 14 0.005 28.60% 65.90% - eQTL 1 53.70% 56.30%
2010012O05Rik 6 17 41 16 0.01 26.10% 71.90% - eQTL 0 56.70% 57.60%
Rgs17 10 24 39 17 0.013 29.40% 69.60% - eQTL 0 54.50% 55.10%
Pdcl 5 13 61 23 0.018 27.80% 72.60% - eQTL 0 56.80% 58.90%
Blcap 6 13 15 2 0.025 31.60% 88.20% - IP 1 25.20% 73.70%
*: Counts of the AKR and PWD allele in the Illumina sequence data after filtering.
†: Reported imprinted status of the known imprinted genes in neonatal brain (IP: imprinted; NR: not reported).
¶: Number of significant SNPs with q -value ? 0.10 for each gene.
$: eQTL : Expression quantitative trait loci
Known IP 
genes
PWD x AKR AKR x PWD
q-value
AKR percentage
Known 
status†
Verified 
status
Sig_SNPs 
(q<0.1)¶
Pyrosquencing
Verified 
status
Sig_SNPs 
(q<0.1)¶
PyrosquencingKnown 
status†
Novel IP genes
PWD x AKR AKR x PWD
q-value
AKR percentage
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Figure 14. Alignment of Illumina sequence reads for Igf2 transcript. The top 
panel is the summary window or all 1,253 cDNA reads that mapped to the 
4,038 bp Igf2 transcript (NM_010514). The blue arrows represent the sense 
reads and the red arrows represent antisense reads. From the figure, most of 
the reads were aligned to the 1 kb region near the 3'-end of the transcript. The 
bottom left panel gives the Illumina read names, and the bottom right gives the 
sequence alignment.  Sense reads are printed in black font and the antisense 
reads are in red font.  There are many overlapping 32-bp reads aligned 
uniquely to the transcript, with a quality score for each nucleotide. There is a 
SNP (A/G) located in the middle. By directly counting the number of reference 
and alternative nucleotides at the SNP, we were able to quantify the relative 
expression level of the two parental alleles.  
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A total of 17 of the 26 candidate genes were verified to be imprinted by a combination 
of Sanger sequencing and Pyrosequencing. Of these, 14 are known imprinted genes. 
Nnat (Peg5), Inpp5f_v2, Rasgrf1, Zrsr1 (U2af1-rs1), Snrpn and Snurf genes are 
known to be imprinted in mouse neonatal brain with paternal-only expression (Table 
14) (Leff et al. 1992; Plass et al. 1996; Kagitani et al. 1997; Wang et al. 2004; Choi et 
al. 2005), and this was confirmed by both the Illumina sequence data and by Sanger 
sequencing and Pyrosequencing (Figure 15, Figure 16,Figure 17,Figure 18, Figure 19, 
Figure 20 and Figure 21). Neuronatin (Nnat), a gene on mouse chromosome 2, is 
known to be imprinted in mouse neonatal brain (Kagitani et al. 1997). In our data, 
Nnat showed 100% paternal monoallelic expression, with a q-value of zero (Table 14). 
Four SNPs within the last exon of the gene were covered by the Illumina reads. All of 
them showed 100% paternal expression as scored in 3,057 observed paternal allele-
bearing reads in both reciprocal F1s (Figure 22A), a result verified by Sanger 
sequencing (Figure 22B) and by Pyrosequencing (Figure 22C).  
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Figure 15. SNP counts in the Illumina data for Inpp5f and Inpp5f_v2. Allele 
counts for Perlegen SNP NES16063345, NES16063347, NES16063348, 
NES16063351, NES16063353, NES16063354 and NES16063356. The blue 
bars (from left to right) stand for the counts from the paternal allele in PWD x 
AKR and AKR x PWD F1s respectively. The red bars represent the maternal 
allele counts. 
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Figure 16. Sanger sequencing verification for Inpp5f at Perlegen SNP 
NES16063356. The target sequence is CTCTGA(C/T)AAGCA. 
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Figure 17. Pyrosequencing verification for Inpp5f at Perlegen SNP 
NES16063356. The target sequence is CTCTGA(C/T)AAGCA. 
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Figure 18. Pyrosequencing sequencing verification of Inpp5f for Perlegen SNP 
NES16063345. The target sequence is CGGTC(C/T)CAGTCT. 
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Figure 19. Pyrosequencing verification for Rasgrf1. The target sequence is 
T(C/T)ACGGGACAA. 
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Figure 20. Sanger sequencing and pyrosequencing verification for Zrsr1 at 
Perlegen SNP NES08366940. The target sequence is 
GGTAAAA(A/G)CTCAGA.  
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Figure 21. Pyrosequencing sequencing verification of Snrpn-Snurf at Perlegen 
SNP NES16116930. The target sequence is (G/T)GAAACCAAGTTCT. 
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Figure 22. Verification for known imprinted gene Nnat (also known as Peg5).  
(A). Allele counts for Perlegen SNP NES08901860, NES08901861, 
NES08901863 and NES08901864. The blue bars (from left to right) represent 
the Illumina read counts from the paternal allele in PWD x AKR and AKR x 
PWD F1s respectively (maternal genotype listed first). The red bars represent 
the maternal allele Illumina read counts.  
(B). Sanger sequencing verification for Perlegen SNP NES08901861. We 
discovered an adjacent SNP position before NES08901861. The target 
sequence is GCCCT(AC/GA)ATCT.  
(C). Pyrosequencing verification for Perlegen SNP NES08901861. The target 
sequence is GCCCT(AC/GA)ATCT. 
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The imprinting status of seven known imprinted genes have not been previously 
reported in neonatal brain, including the paternally expressed Peg13, Sgce, Impact and 
Nap1l5 (Table 14; Figure 23, Figure 24, Figure 25 and Figure 26) (Piras et al. 2000; 
Smith et al. 2003) and the maternally expressed Gtl2 (Meg3), H19 and Cdkn1c 
(P57KIP2) (Table 14; Figure 27 and Figure 28) (Hatada and Mukai 1995; Hagiwara et 
al. 1997; Hemberger et al. 1998; Schmidt et al. 2000).  Our data support their being 
imprinted in P2 neonatal brain (Table 14). Gtl2 (also known as Meg3) is a non-coding 
RNA gene on mouse chromosome 12, and it is reported to be imprinted in mouse 
placenta (Schmidt et al. 2000). Although the expression pattern of Gtl2 has been 
determined in brain (Yevtodiyenko et al. 2004; McLaughlin et al. 2006), the 
imprinting status was not tested in neonatal brain. There is no Perlegen SNP covered 
in the Illumina data, but from the assembly of the Illumina reads, 4 novel SNPs were 
discovered and it is suggested that the Gtl2 transcript (XR_035484) is expressed only 
from the maternal allele (Figure 29A). This is confirmed by Pyrosequencing (Figure 
29B). Another splicing variant of Gtl2, NM_144513, was identified to be imprinted in 
our custom Agilent microarray survey of novel imprinted genes (See Chapter 1), with 
1,847-fold difference in probe intensity in PWD x AKR cross and 793-fold in the 
reciprocal cross. A Perlegen SNP (NES17649478) in NM_144513 but not XR_035484 
was verified by Pyrosequencing (Figure 29C). The analysis shows unambiguously that 
both splice variants are imprinted. Careful examination of the in situ images of fetal 
brain of uniparental disomic mice are consistent with our findings and suggest that 
there is maternal expression only (da Rocha et al. 2007). 
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Figure 23. Pyrosequencing sequencing verification for Peg13. The target 
sequence is TAG(C/T)TATAG. 
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Figure 24. Sanger sequencing (left) and pyrosequencing verification (right) for 
known imprinted gene Sgce at Perlegen SNP NES10338539. The target 
sequence is ACC(G/A)TGACACA. 
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Figure 25. Pyrosequencing sequencing verification for known imprinted gene 
Nap1l5. The target sequence is AAT(A/G)CAAATATTTA. 
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Figure 26. Pyrosequencing sequencing verification for known imprinted gene 
Impact at Perlegon SNP NES12698107. The target sequence is 
(G/A)TTCCTCAC. 
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Figure 27. Pyrosequencing sequencing verification for H19. The target 
sequence is C(G/A)TCCATC. 
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Figure 28. Pyrosequencing sequencing verification for known imprinted gene 
Cdkn1c. The target sequence is C(C/T)ACTTCAT. 
 
 
  
 76 
 
 
 
 
Figure 29. Verification for the known imprinted gene Gtl2. 
(A). Allele counts for the 4 new SNPs discovered by assembling the Solexa 
reads. The blue bars (from left to right) stand for the counts from the paternal 
allele in PWD x AKR and AKR x PWD F1s respectively. The red bars 
represent the maternal allele counts. Four novel SNPs were discovered in one 
Gtl2 transcript (XR_035484), consistent with monoallelic expression from the 
maternal allele in both reciprocal crosses and confirmed by Pyrosequencing. 
Another splicing variant of Gtl2, NM_144513, previously was found by us to be 
imprinted using a custom Agilent allele-specific microarray (See Chapter 1), 
with an 1,847-fold difference in probe intensity in PWD x AKR cross and 793-
fold in the reciprocal cross. A Perlegen SNP (NES17649478) in NM_144513 
but not XR_035484 was verified by Pyrosequencing.  We conclude that both 
XR_035484 and NM_144513 are imprinted in the neonatal brain.  
(B). Pyrosequencing verification for a novel SNP in Gtl2. The target sequence 
is TGT(A/G)GAGGGA.  
(C). Pyrosequencing verification for Perlegen SNP NES17649478. The target 
sequence is GA(A/G)GATAG.   
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Known and novel imprinted genes identified  
We also discovered three novel imprinted genes by Illumina short-read sequencing, 
and verified by Sanger and Pyrosequencing. According to Choi et al. (Choi et al. 
2005), Inpp5f is a splicing variant of the known imprinted gene Inpp5f_v2, sharing 4 
exons and part of the last exon. There are seven SNPs covered in the sequence data for 
Inpp5f, with 2 of them shared by Inpp5f_v2. Since all seven SNPs show significant 
paternal-excess in expression, we conclude that Inpp5f is also imprinted in P2 neonatal 
brain. Formally, it is also possible that Inpp5f and Inpp5f_v2 share the same 3’ end.  
Two CpG islands near the gene region were reported before (Choi et al. 2005). CpG1 
is not methylated and CpG2 is the DMR (Differentially Methylated Region) with only 
the paternal allele being methylated. Two previously reported non-imprinted genes, 
1810044A24Rik (Davies et al. 2004) and Blcap (Evans et al. 2005), are found to be 
predominantly maternally expressed novel imprinted genes in our sequence data (q-
value 0.0011 and 0.025) and Pyrosequencing verified that they showed 80% 
expression from the maternal allele (Figure 30)(Figure 31). The imprinting status of 
1810044A24Rik was also verified by Pyrosequencing in reciprocal crosses of 
C57BL/6 and C3H/HeJ (Figure 30). The imprinting status for Blcap was not verified 
in C57BL/6 and C3H/HeJ due to lack of exonic SNPs. Two known imprinted genes, 
Peg13 and Nnat, are located in the introns of 1810044A24Rik and Blcap, respectively. 
The CpG island of Peg13 is only methylated at the maternal allele (Smith et al. 2003). 
Five differentially methylated CpG sites within the gene region of Nnat were 
previously identified (Kikyo et al. 1997; Smith et al. 2003), so each of the three novel  
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Figure 30. Verification for known imprinted gene 1810044A24Rik. (A). Sanger 
sequencing verification for Perlegen SNP NES12099717. The target sequence 
is TCCATA(T/C)GCCATA. (B). Pyrosequencing sequencing verification for 
Perlegen SNP NES12097854 in AKR and PWD reciprocal cross. The target 
sequence is (A/G)TTCAGGA. (C). Pyrosequencing sequencing verification for 
Perlegen SNP NES12098495 in C3H and B6 reciprocal cross. The target 
sequence is AG(C/T)TGCTT. 
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Figure 31. Pyrosequencing sequencing verification for novel imprinted gene 
Blcap at Perlegen SNP NES08901938. The target sequence is 
AC(A/G)AGAATA.. 
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imprinted genes have DMRs near or within the gene regions. Nine genes attained 
marginal significance only after pooling across all SNPs, but showed no single SNP 
with a significantly skewed frequency.  In all 9 cases, Pyrosequencing demonstrated 
unambiguously that they were not imprinted (Table 14). 
 
Coverage of known imprinted genes in this study 
Among the 98 known imprinted genes in mouse, 45 have both RefSeq ID and SNPs 
between AKR and PWD strains. 33 of the 45 known imprinted genes with SNPs were 
covered in our short-read sequence data. The remaining 12 genes were not covered by 
filtered high quality SNP-containing reads due to lack of detected expression in mouse 
neonatal brain (Table 15). 14 of 33 covered known imprinted genes are significant 
(Table 14). In the non-significant maternally expressed imprinted genes, Ppp1r9a, 
Asb4, Calcr and Ube3a have been reported as being imprinted in brain (Albrecht et al. 
1997; Mizuno et al. 2002; Hoshiya et al. 2003; Ono et al. 2003), and they all have a 
marginally significant P-value. Ube3a imprinting was verified by Pyrosequencing. 
Genes that have too low a high-quality SNP-containing read count, such as Gnas, 
Gatm, Tnfrsf23, Zim1, Dcn, Nap1l4, Osbpl5, Grb10 and Slc22a2 have an imprinting 
status that remains inconclusive, but the data are not consistent with strong imprinting 
(Table 15). All known maternally expressed genes covered with adequate depth of 
sequence reads had a pattern of allelic bias consistent with their known imprinting 
status. Gtl2, H19, Cdkn1c and Commd1 are significant in the Illumina data and they 
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are verified to be imprinted in neonatal brain. Ppp1r9a has significant nominal P-
value but is not significant after multiple test correction. However, the Illumina counts 
are consistent with preferential maternal expression (Table 16). Asb4, Calcr, Ube3a 
has marginal significant P-value due to the small number of SNP-containing reads 
covered in the data, suggesting that they might be imprinted in neonatal brain. We 
verified that Ube3a is imprinted in neonatal brain by the Pyrosequencing method, with 
the p1 and p2 ratios 0.392 and 0.755. The other genes covered in the data, Gatm, 
Tnfrsf23, Zim1, Dcn, Nap1l4, Osbpl5, and Slc22a2 are not significant, which is 
consistent with the fact that they are known to be imprinted in placenta instead of 
neonatal brain (Table 16). Gnas, a known imprinted gene in the pituitary but not in the 
whole brain of mouse (Yu et al. 1998; Weinstein et al. 2000; Weinstein et al. 2001; 
Weinstein et al. 2004), is not statistically significant in the Illumina data. However, the 
Pyrosequencing verification showed 0.459/0.562 ratio of p1 /p2, suggesting that there 
is slightly higher expression from the allele inherited from mother. Grb10 is imprinted 
in both placenta and brain (Blagitko et al. 2000; Mergenthaler et al. 2001; Hikichi et 
al. 2003) but does not show a significant difference between p1 and p2 in the Illumina 
data, despite adequate expression level to provide a test of adequate power.   
Subsequent Pyrosequencing verified the non-imprinting status in P2 neonatal brain 
(Table 16). In fact, Grb10 is imprinted in mouse brain with paternal-only expression, 
but it shows maternal-only expression in other tissues (Hikichi et al. 2003). It could be 
possible that Grb10 is imprinted in other stages of brain (for example, fetal brain) but 
not P2 brain in mouse, or it is possible that the imprinting status varies among strains, 
and the AKR x PWD F1 fail to imprint Grb10. For the paternally expressed known 
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imprinted genes that are not statistically significant in our data, Magel2 and Peg3 are 
consistent with 100% paternal expression. Rtl1 and Copg2 may be maternally 
expressed, as suggested by the sequence count data, but there were too few reads to 
attain statistical significance. While Copg2 is maternally expressed, and Rtl1 is 
expressed from the paternally inherited allele, the microRNA-containing antisense 
transcript is expressed from the maternal allele (Seitz et al. 2003). Igf2 and Slc38a4 
are consistent with non-imprinting and, consistent with the pattern of expression in 
human and mouse (DeChiara et al. 1991; Ohlsson et al. 1994; Jones et al. 2001; 
Charalambous et al. 2004),  Igf2 is verified by Pyrosequencing to be biallelically 
expressed in brain (Figure 32 and Table 16).  
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Table 15. Summary of known imprinted genes covered in IIlumina P2 brain 
reads. 
Type Count Description
No_RefSeq 37 The gene is not in the RefSeq database
No_SNP 16 There is no SNP in the RefSeq transcript.
No_counts 12 There is SNP site within the transcripts, but there is no counts in the filtered Solexa data.
Covered 33 The gene is covered in the Solexa data.
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Table 16. Known imprinted genes covered in Illumina P2 brain data. 
AKR 
count
PWD 
count
AKR 
count
PWD 
count p1 p2
Gtl2 * M 1 339 193 1 0 0.000 1.000 placenta 452
H19 * M 2 14 61 1 1.68E-12 0.094 1.000 fetal brain 247
Cdkn1c * M 0 8 13 0 9.46E-07 0.036 1.000 whole body of neonates 521
Commd1 M 12 33 22 7 2.52E-05 0.412 0.725 brain 574
Ppp1r9a * M 36 54 67 26 1.18E-05 placenta, partially in neonatal brain 2117
Asb4 M 3 5 8 0 0.01292505 brain & placenta 158
Calcr M 0 1 6 0 0.05666007 embryonic and adult brain 77
Ube3a * M 3 10 4 2 0.08214854 0.392 0.755 brain 1660
Gnas * M 181 214 101 96 0.2167333 0.459 0.562 other (embryos), Imprinted in 
pituitary 
15998
Gatm M 4 5 15 7 0.22626793 placenta 637
Tnfrsf23 M 2 2 2 0 0.37311385 placenta 17
Zim1 M 0 1 2 1 0.5 other tissue, biallelic in neonatal 
brain
19
Dcn M 16 10 4 4 0.59255371 placenta 344
Nap1l4 * M 9 12 181 214 0.7968901 placenta 1175
Osbpl5 M 3 2 5 4 0.96653274 placenta 157
Grb10 * M 2 3 6 10 0.98294642 0.609 0.522 placenta and brain 508
Slc22a2 M 0 1 0 1 1 placenta 11
Nnat P 1182 1 21 1853 0 1.000 0.000 neonatal brain 8561
Snurf P 888 1 1 18 0 1.000 0.000 neonatal and adult brain 23679
Snrpn P 889 1 1 19 0 1.000 0.000 neonatal and adult brain 23310
Peg13 * P 168 0 6 74 0 0.988 0.030 adult brain 1088
Nap1l5 * P 22 0 0 67 2.42E-22 1.000 0.000 adult brain 2329
Inpp5f_v2 P 38 3 14 80 4.29E-19 0.919 0.078 neonatal brain 5509
Sgce P 9 0 0 54 6.01E-12 adult brain & placenta 313
Rasgrf1 * P 16 0 0 20 2.56E-11 1.000 0.000 neonatal brain 93
Impact P 15 6 8 83 6.24E-09 0.791 0.198 embryonic and adult brain 1953
Zrsr1 P 11 0 1 14 4.48E-07 0.975 0.004 embryonic, neonatal and adult brain 204
Magel2 P 2 0 0 5 0.01614973 adult brain 171
Rtl1 P 0 3 2 0 0.0576 brain and placenta 62
Peg3 P 2 0 0 2 0.125 embryonic, neonatal and adult brain 52
Igf2 * P 52 43 20 27 0.17846458 0.641 0.499 placenta, biallelic in fetal brain 247
Copg2 P 0 1 2 0 0.22222222 embryonic, neonatal and adult brain 302
Slc38a4 P 2 2 12 6 0.58003101 brain and placenta 45
*: assembly information used.
known maternally expression imprinted genes that are significant in the Illumina data
known maternally expression imprinted genes that are not significant in the Illumina data
known paternally expression imprinted genes that are significant in the Illumina data
known paternally expression imprinted genes that are not significant in the Illumina data
Reported imprinting status in 
brain and placenta
# of 
perfectly 
matched 
reads
MGIsymbol Exp. 
allele
PWD x AKR AKR x PWD
Storer-Kim 
p-value
Pyrosquencing
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Figure 32. Pyrosequencing sequencing verification for Igf2.The target 
sequence is (C/T)AAGAGGGGAT. 
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Closely-linked pairs of imprinted genes 
Of the 10 sense-antisense pairs of known imprinted genes discovered to date (Morison 
et al. 2005), eight pairs are reciprocally imprinted (maternal expression for sense 
transcripts and paternal expression for antisense transcripts, or vice versa) (Barlow et 
al. 1991; Kay et al. 1994; Albrecht et al. 1997; Gould and Pfeifer 1998; Paulsen et al. 
1998; Hu et al. 1999; Peters et al. 1999; Kim et al. 2000; Lee et al. 2000; Chamberlain 
and Brannan 2001; Kim et al. 2001; Sado et al. 2001; Fitzpatrick et al. 2002; Coombes 
et al. 2003; Seitz et al. 2003) (Table 17). The remaining two show only paternal 
expression (DeChiara et al. 1991; Moore et al. 1997; Jong et al. 1999).  These cases 
of imprinting all were discovered and verified individually in different samples using 
different mouse strains (Table 17). In our Illumina sequence data, three reciprocally 
expressed closely linked sense-antisense (or sense-sense) pairs were covered 
adequately to perform statistical analysis (Table 18). Four of them are known 
imprinted genes (Peg13, Nnat, Zrsr1, Commd1) and two (1810044A24Rik, Blcap) are 
among our verified novel imprinted genes. Peg13, Nnat and Zrsr1 are located in an 
intron of 1810044A24Rik, Blcap and Commd, respectively. Interestingly, in the three 
pairs, Peg13-1810044A24Rik, Nnat-Blcap and Zrsr1-Commd1, the first gene is a 
paternally expressed imprinted gene with 100% monoallelic expression, whereas the 
second gene is maternally expressed partially imprinted gene (Figure 33). The pattern 
is consistent with the possibility that the monoallelic expression of the paternally 
expressed sense transcripts might reduce the relative expression of the paternal copy 
of the antisense transcript, resulting in predominantly maternal expression. Our 
hypothesis is that the paternally expressed imprinted gene is driving the apparent 
imprinting of the maternal gene, presumably through transcriptional interference.  
While this reciprocal imprinting has been noted in the literature (Sleutels et al. 2002; 
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Sleutels et al. 2003; Wang et al. 2004) , this is the first genome-wide study identifying 
multiple, well quantified cases in mouse neonatal brains.  
 
Transcriptome-wide pattern of imprinting status 
To investigate the pattern of imprinting status for all the transcripts covered by our 
study, we plotted the 5,076 unique Entrez genes with counts of four or more in both 
reciprocal crosses across the mouse genome (Figure 34). We define imprinting status 
as the difference between the AKR percentages in the two reciprocal crosses, which is 
p1-p2 (Table 11). Most genes display a value of p1-p2 close to zero, indicating a lack of 
significant imprinting. The sense-antisense pairs and the imprinted genes in known 
imprinting clusters are clearly demonstrated in the genome-wide plots. There are 1,606 
non-significant genes with a total count 25 or more in both reciprocal crosses, forming 
a good tissue-specific non-imprinted dataset for computational prediction and 
evolutionary analysis. 
Paternal-brain and maternal placenta bias of imprinted genes 
When paternally- and maternally-expressed imprinted genes covered in the sequence 
read data are compared, we discovered an excess of paternal expression (11 paternal 
and 6 maternal), and most of these (9 of 11) show strong monoallelic expression 
(90%-100%). Three of the maternally expressed genes are only partially imprinted in 
brain with 70%-80% expression from the maternal allele (Table 14).  Overall there is 
a bias toward paternally expressed imprinted genes in brain, whereas of the 29 genes 
reported to be imprinted in placenta, only 8 are paternally expressed.  
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Table 17. Sense-antisense pairs in known imprinted genes.
Chr band Type MGIsymbol Expressed 
allele
Description
 2 E1-H3 coding-gene Gnas M Stimulatory G-protein, alpha subunit 
 2 E1-H3 antisense Nespas P Nesp antisense
6 A3 coding-gene Copg2 P Coatomer protein complex subunit
6 A3 antisense Copg2as2 M COPG2 antisense
7 B5 coding-gene Mkrn3 (Zfp127) P Makorin, ring finger protein
7 B5 antisense Zfp127as P Mkrn3 antisense
 7 A2-B1 coding-gene Usp29 P Ubiquitin-specific protease
 7 A2-B1 antisense Zim3 M antisense of Usp29
7 B5 coding-gene Ube3a M Ubiquitin protein ligase
7 B5 antisense UBE3A-AS P UBE3A antisense
7 F5 coding-gene Igf2 P Insulin-like growth factor 2
7 F5 antisense Igf2as P IGF2 antisense 
7 F5 coding-gene Kcnq1 M Voltage-gated potassium channel
7 F5 antisense Kcnq1ot1 P KCNQ1 antisense
12 F1 coding-gene Rtl1(Peg11) P Retrotransposon-like 1, like gag protein
12 F1 antisense anti-Rtl1 M Rtl1 antisense 
17 A1 coding-gene Igf2r M Insulin-like growth factor receptor 2
17 A1 antisense Air P Igf2r antisense
X D Non-coding RNA Xist P XIST
X D antisense Tsix M XIST antisense
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Table 18. Closely linked and reciprocal imprinted genes covered in Illumina 
data. 
AKR PWD AKR PWD p1 p2
Peg13 chr15 168 0 6 74 0 1.000 0.075 100%
1810044A24Rik chr15 7 20 25 5 1.08E‐03 0.259 0.833 Partially
Nnat chr2 1182 1 21 1853 0 0.999 0.011 100%
Blcap chr2 6 13 15 2 0.0252 0.316 0.882 partially
Zrsr1 chr11 11 0 1 14 6.68E‐05 1.000 0.067 100%
Commd1 chr11 12 33 22 7 2.55E‐03 0.267 0.759 partially
IP statusGene_name Chr PWD x AKR AKR x PWD q‐value AKR percentage
 
 
  
 91 
 
 
 
 
 
Figure 33. Sense-antisense gene pairs covered by the Illumina sequence 
data. Gene structures of the three gene pairs showing nested structures. The 
blue shading represents the paternal allele and the pink shading indicates for 
the maternal allele. Boxes with dashed lines indicate no expression. The 
arrows represent the direction of transcription. The sum of the heights of the 
two parental exons for each gene is in proportion to the expression level, 
which is quantified by the total counts of the perfect-match Illumina reads. The 
relative heights of the exons for the paternal and maternal allele within the 
same gene represent the relative expression level of the two parental alleles. 
The short vertical lines under the exons indicate the SNP positions, and the 
total counts of the two reciprocal crosses for the maternal and paternal allele 
are labeled.  
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Figure 34. Chromosomal scans of imprinting status.  
(A). Imprinting status for chromosome 2. (B). Imprinting status for 
chromosome 7. Each plot contains unique Entrez genes covered by SNP-
containing Illumina reads with counts no less than 4 in both reciprocal crosses.  
The height of each bar is the difference of the AKR percentage in the two 
reciprocal crosses (p1-p2), representing the intensity of imprinting. The color 
stands for the direction of imprinting, blue for paternal expression and red for 
maternal expression. The intensity of the color represents the significance, 
grey for not significant (q-value ≥ 0.10), lighter blue and pink for marginally 
significant (0.05 ≤ q-value < 0.10), darker blue and red for significant (q-value 
< 0.05). The gene name is indicated if | p1-p2| ≥ 0.3.  
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Discussion	
Quantifying allele-specific expression with accurate ratios by directly counting 
the SNPs 
Genomic imprinting is not always an “all-or-none” effect with 100% from the paternal 
or maternal allele. Instead, the degree of imprinting falls on a continuum from 
complete uniparental expression to equal expression of the two parental alleles. 
Microarray hybridization can identify uniparental expression, but it cannot give 
reliable ratios of the two parental alleles, since there is no good means to quantify the 
affinity difference between perfect and mismatch probes. The method of direct Sanger 
sequencing of the cDNA is not quantitative and will miss those cases with quantitative 
differences between maternal vs. paternal expression. To solve these problems, we 
sequenced the entire transcriptomes of mouse reciprocal F1 neonatal brains by the 
Illumina/Illumina sequencing method, and obtained relative expression ratios of the 
two parental alleles by counting the allele-specific sequence reads at the SNP positions 
within the transcripts. The method is well validated by independent methods 
(Pyrosequencing and Sanger sequencing).  We present discoveries of the imprinting 
status of many genes for the neonatal brain, including genes not known to be 
imprinted in any tissue. Scoring allele-specific expression by short read transcriptome 
sequencing will be widely used whenever allele-specific differential expression is of 
interest, including quantification of cis-acting regulatory SNP effects (Nagalakshmi et 
al. 2008). 
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The path to exhaustive profiling of tissue- and developmental stage-specific 
genomic imprinting  
The discovery of imprinted genes in humans and mice remains sporadic due to the hit-
or-miss way that these genes have been discovered. Different studies used different 
mouse strains, testing imprinting status in different tissues and developmental time 
points, and none of the studies published to date has employed a truly transcriptome-
wide screen for imprinting. Our study shows a way to quantitatively assess in a highly 
uniform manner the imprinting status of the entire transcriptome for each tissue. The 
uniformity of the short-read sequencing approach has clear advantages, and paves the 
way toward a catalog of imprinting status of all transcribed genes in the mouse and 
human.  
 
Imprinting of nested and closely-linked genes 
Our short-read transcriptome sequencing approach identified three pairs of closely 
linked and reciprocally imprinted genes in which the paternally expressed genes 
showed 100% monoallelic expression whereas the maternally expressed genes are 
only partially imprinted in neonatal brains. These data are consistent with the scenario 
in which the paternally expressed gene is strongly imprinted, and by virtue of its 
imprinting, there is transcriptional interference, driving weaker expression of genes 
that are transcribed from the opposite strand (or are nested within the first transcript).  
This would impose an appearance of weak maternally expressed imprinting. The 
implications of the bias toward maternal expression in partially imprinted genes, 
paternal expression of strongly imprinted genes, and the apparent transcriptional 
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interference of opposing strand transcripts all await further analysis to understand the 
mechanism regulating their imprinting as well as their functional and evolutionary 
implications.  
 
How many imprinted genes are there in the genome?  
It has been estimated that about 1% of the genes in the mammalian genome are 
imprinted. However, this estimate has a wide range, from around 100 genes (Luedi et 
al. 2007) to 600 genes (Luedi et al. 2005), to more than 2,000 genes (Nikaido et al. 
2003). The variation is due to the ignorance of tissue-specificity of imprinting status 
and the inability to make inference about non-imprinted genes. Using our method, by 
counting the reads that correspond to the two parental alleles, we can specify the 
statistical confidence that a gene is not imprinted, as well as identifying those that are 
only partially imprinted.  This enables determination of the statistical confidence that 
this list of imprinted genes is close to exhaustive in neonatal brains. In addition to the 
three novel imprinted genes we found in neonatal brain, we confirmed the imprinting 
status of 7 known imprinted genes and we also discovered the novel imprinting status 
in neonatal brain of 7 additional genes known to be imprinted in other tissues. With 
our coverage of more than 5,000 transcripts, we did not discover novel imprinting 
clusters, and only a small number of novel imprinted genes were found.  Taken 
altogether, the data suggest that the list of genes that are imprinted in the neonatal 
brain is nearly complete, and the only remaining ones to be discovered are either 
expressed at very low levels, show a small parent-of-origin bias, or are imprinted in 
only a small portion of the brain.   
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CHAPTER 3  
Identification of novel imprinted genes in mouse placenta from RNA-seq data2 
Abstract 
Many questions about the regulation, functional specialization, computational 
prediction, and evolution of genomic imprinting would be better addressed by having 
an exhaustive genome-wide catalog of genes that display parent-of-origin differential 
expression.  As a first-pass scan for novel imprinted genes, we performed mRNA-seq 
experiments on E17.5 mouse placenta cDNA samples from reciprocal cross F1 
progeny of AKR and PWD mouse strains, and quantified the allele-specific expression 
and the degree of parent-of-origin allelic imbalance. We confirmed the imprinting 
status of 23 known imprinted genes in the placenta, and found that 12 genes reported 
previously to be imprinted in other tissues are also imprinted in mouse placenta.  
Through a well-replicated design using an orthogonal allelic-expression technology, 
we verified five novel imprinted genes that were not previously known to be imprinted 
in mouse.  Our data suggest that most of the strongly imprinted genes have already 
been identified, at least in the placenta, and that evidence supports perhaps 100 
additional weakly imprinted genes.  Despite previous appearance that the placenta 
tends to display an excess of maternally-expressed imprinted genes, with the addition 
of our validated set of placenta-imprinted genes, this maternal bias has disappeared. 
 
  
                                                 
2 This work was published in Wang X, Soloway PD, Clark AG., 2011. A Survey for Novel Imprinted 
Genes in the Mouse Placenta by mRNA-seq. Genetics, [Epub ahead of print]. 
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Introduction 
 
Genomic imprinting occurs when the expression of the maternal and paternal copies of 
a gene differ in a parent-of-origin dependent manner (Reik and Walter 2001). Several 
of the mechanisms of genomic imprinting are shared by higher plants and therian 
mammals, involving differential DNA methylation, non-coding RNA and/or histone 
modifications (Delaval and Feil 2004; Pauler and Barlow 2006; Hudson et al. 2010), 
although imprinting almost certainly arose independently in these lineages.  
Imprinted genes are often expressed and imprinted in a tissue- and developmental 
stage-specific manner. Although known imprinted genes tend to be clustered in the 
genome, there has been an ascertainment bias in concentrating the search among 
nearby genes for new imprinted candidates, motivating a need for a more balanced 
genome-wide scan.  The occurrence of medical disorders associated with defects in 
imprinting provides further motivation to produce an exhaustive identification of 
imprinted genes.  Because one allele is virtually silenced, mutations transmitted from 
the expressing parent behave in a dominant fashion, as is seen in many human 
disorders associated with defects in imprinted genes (Jiang et al. 2004; Butler 2009).  
 
To date, more than 100 imprinted genes have been discovered in the mouse (Morison 
et al. 2005), but the list is not exhaustive. Transcriptome-wide and genome-wide 
attempts to search for novel imprinted genes have exploited different approaches 
(Maeda and Hayashizaki 2006; Henckel and Arnaud 2010). Genome-wide 
bioinformatic predictions have successfully identified novel imprinted genes in human 
and mouse (Yang et al. 2003; Luedi et al. 2005; Luedi et al. 2007; Brideau et al. 
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2010), but the prediction power is low because the training set of known imprinted 
genes is small, and the genomic clustering of imprinted genes violates independence 
of the imprinting signals (Daelemans et al. 2010). Earlier experimental approaches 
such as expression microarrays on parthenogenetic and androgenetic embryos 
(Mizuno et al. 2002; Kuzmin et al. 2008; Sritanaudomchai et al. 2010), expression 
arrays on uniparental disomic (UPD) mice (Choi et al. 2001; Choi et al. 2005; Schulz 
et al. 2006), and allele-specific expression arrays on individuals with informative 
SNPs (Pollard et al. 2008; Brideau et al. 2010) have identified many novel imprinted 
genes on a larger scale than the single-gene approach. However, these methods require 
an abnormal configuration of the genome and can only cover a subset of genes 
included in the array design or the UPD region. DNA methylation-based methods have 
successfully identified a number of novel imprinted genes (Peters et al. 1999; Smith et 
al. 2003). This method first searches for differentially methylated regions (DMR), then 
examines the genes in close proximity to each novel DMR. Since not all imprinted 
genes have an associated DMR, even this approach will likely miss some novel 
imprinted genes.  To overcome these problems and begin to identify imprinted genes 
transcriptome-wide in a variety of tissues, we (Wang et al. 2008) and other 
investigators (Babak et al. 2008; Gregg et al. 2010a; Gregg et al. 2010b) have carried 
out mRNA-seq studies to identify novel imprinted genes through differential allele-
specific expression in reciprocal F1 plants and animals. Wang et al. and Babak et al. 
are the first studies using RNA-seq of mouse reciprocal crosses to search for novel 
imprinted genes. Wang et al. performed RNA-seq of mouse neonatal day 2 (P2) brains 
from reciprocal crosses of AKR and PWD strains. We discovered and confirmed 14 
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known and 3 novel imprinted genes in P2 brains. Babak et al. did transcriptome 
sequencing on embryonic day 9.5 (E9.5) embryos in CAST/EiJ and C57BL/6J 
reciprocal crosses and they found 14 imprinted genes which are all known in mouse. 
No novel imprinted genes emerged from this study. Recently, Gregg et al. published 
an RNA-seq study on embryonic and adult brains of CAST/EiJ and C57BL/6J 
reciprocal crosses. Whole E15 brain, adult cortex, and adult hypothalamus samples 
were sequenced and analyzed, and they claimed more than 1,300 genes showed 
differential parental allelic expression in the brain. It is clear that RNA-seq provides a 
powerful tool for scoring parent-of-origin differential expression, and that differences 
in targeted tissue, developmental stage, sequence quantity, methods of validation may 
contribute to differences across studies. 
 
In the mouse, most of the known imprinted genes are expressed and imprinted in the 
brain and/or placenta (Morison et al. 2005). The placenta is a mammalian-specific 
organ, which has important nutritional transport and immune functions for fetal 
growth.  The placenta has been a primary target organ in studies of genomic 
imprinting in terms of the number and importance of known imprinted genes 
(Wagschal and Feil 2006; Frost and Moore 2010), motivating this RNA-seq analysis 
of reciprocal F1 mice to discover novel imprinted genes. Since all three previous 
transcriptome-wide RNA-seq studies were focused on brain or embryonic tissue, our 
first-pass survey in mouse placenta will complement previous studies and provide 
information on a tissue of particularly focused interest to the imprinting community.  
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Materials and Methods 
Mouse Strains and crosses 
The four mouse strains (AKR/J, PWD/PhJ, C57BL/6 and CAST/EiJ) and the two 
reciprocal crosses with two strain combinations (PWD/PhJ x AKR/J, AKR/J x 
PWD/PhJ and C57BL/6 x CAST/EiJ, CAST/EiJ x C57BL/6) were described in (Wang 
et al. 2010). We dissected E17.5 placenta tissues from the F1 mice from the following 
crosses: AKR/J female x PWD/PhJ male cross (AKR x PWD for short), PWD/PhJ 
female x AKR/J male (PWD x AKR for short), C57BL/6 female x CAST/EiJ male 
(B6 x CAST for short), and CAST/EiJ female x C57BL/6 male (CAST x B6 for 
short). To minimize maternal contamination, we cut only the fetal side of the placenta 
tissue during dissection. E17.5 was chosen because it is late enough to be able to get 
enough tissue in these dissections, but early enough to make it fairly easy to avoid 
maternal contamination. 
 
We extracted the total RNA samples from the placentas harboring the F1 progeny 
using Qiagen RNeasy Plus Mini Kit (Qiagen, CA). The RNA concentrations and A260 
nm/A280 nm ratios were quantified with a NanoDrop ND-1000 Spectrophotometer 
(Thermo Scientific, DE). RNA integrity was tested using the Agilent 2100 
Bioanalyzer (Agilent Technologies, Inc, CA). All of the samples had a RIN (RNA 
integrity number) in the range 9.6-10.0 (RINmax = 10.0).  AKR/J and PWD/PhJ 
genomic DNA were purchased from the Jackson Laboratory (www.jax.org).   
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Illumina mRNA sequencing of the F1 placenta transcriptome 
Our initial mRNA-seq was performed on total RNA samples from one AKR female x 
PWD male and one PWD female x AKR male placenta using an Illumina Genome 
Analyzer (Illumina Inc., CA). The mRNA-seq libraries were made with 5 µg of 
starting total RNA samples using the mRNA-Seq 8-Sample Prep Kit (Illumina Inc., 
CA), following the Illumina protocol for mRNA sequencing sample preparation. Eight 
Illumina GA lanes were sequenced for the AKR x PWD library and seven lanes for the 
PWD x AKR library. Image analysis and base calling were performed by the Illumina 
instrument software. In total, our initial screen consisted of 66.0 million short reads 
(read length 44 bp) for the AKR x PWD cross, and 63.3 million reads for the PWD x 
AKR cross. 
 
mRNA-seq Alignment and quantification of total and allele-specific expression 
The reads were truncated to 40 bp and aligned to the mouse reference genome (NCBI 
B37) using BWA with a maximum of four mismatches (Li and Durbin 2009). On 
average, 55.2% of the reads were mapped uniquely to the reference genome. 
Alignment counts in the exon regions were summarized by custom scripts. To identify 
reads that mapped to the exon-intron junctions, we built a junction database by 
extracting all possible junction sequences, based on the gene and exon models from 
the Ensembl database (www.ensembl.org). 4.8% of the total reads were mapped to the 
exon-intron junctions. The exon and junction counts were normalized by the transcript 
length and the total number of mapped reads to compute RPKM (Mortazavi et al. 
2008).  We covered 12,532 unique Ensembl genes (41,110 Ensembl transcripts) with 
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RPKM ≥ 1. If we use a more stringent cut-off of RPKM ≥ 5, then 6,794 unique genes 
(20,026 transcripts) are retained.   
 
To quantify the allele-specific expression in the two reciprocal crosses, at each 
identified SNP position we counted the reads with the reference allele as well as reads 
with the alternative allele (Wang et al. 2008). In addition to using the known sequence 
differences between the mouse strains used, we also performed de novo SNP calling 
from the uniquely aligned reads using SAMtools software (Li et al. 2009), followed by 
our own post-filtering scripts.  To determine the transmission direction, we used the 
AKR/J allele information from the Sanger mouse genome project 2010-03 SNP 
release (http://www.sanger.ac.uk/resources/mouse/genomes/). Since there is imprinted 
X inactivation in the mouse placenta (Huynh and Lee 2005; Sado and Ferguson-Smith 
2005), SNPs with an X-chromosome homolog will mistakenly suggest a maternally-
expressed imprinted gene. To eliminate this bias, we BLATed all SNPs with sequence 
from 50 bp upstream and 50 bp downstream to the genome 
(http://genome.ucsc.edu/cgi-bin/hgBlat?command=start). We removed all SNPs with 
an X chromosome BLAT hit with matched with length 40 or more (equal to the read 
length).   
 
In total, 43,510 high quality autosomal SNPs with 4 or more counts in each of the two 
reciprocal crosses were identified. 41,953 SNPs (96.4%) are within 1 kb upstream or 
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downstream of Ensembl gene models. Manual annotation was performed for three 
known imprinted genes that are not in the Ensembl database (Peg10, Rian, Mirg). 
Because both the AKR and PWD alleles in the F1 transcriptome are mapped to the 
reference genome, which was assembled from the B6 strain, there will be genome 
mapping bias toward the AKR allele if we use the same cut-off for both alleles (AKR 
is closer to B6 than it is to the PWD strain in terms of genetic distance). To remove 
this mapping bias, we generated a pseudo-genome, by replacing the reference allele in 
the genome with the alternative allele. Then we redid the alignment with the same cut-
off to the pseudo-genome. We used the averaged counts from the reference genes and 
pseudo-genome as the final SNP count summary.  
 
Detection of significant parent-of-origin effects and identification of candidate 
imprinted genes 
To select candidate imprinted genes for verification, we applied a formal statistical test 
to the 2 x 2 contingency table formed by the tally of reads of the two alleles in the two 
reciprocal crosses (Wang et al. 2008).  In addition to using this statistical significance, 
we also filtered the results based on the magnitude of the allelic expression bias.  We 
define p1 as the AKR allele percentage in the AKR x PWD cross and p2 as the AKR 
allele percentage in the PWD x AKR cross. For a 100% maternally expressed 
candidate imprinted gene, we expect p1 = 1 and p2 = 0. For partially imprinted genes 
with preferential maternal expression, we used a cut-off of p1 > 0.65 and p2 < 0.35 
(and similarly, we selected the paternally expressed imprinted candidates with a cut-
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off of p1 < 0.35 and p2 > 0.65). This cut-off is somewhat arbitrary, but it was meant to 
avoid the inclusion of genes with a weak allelic imbalance that would otherwise be 
included in our imprinted candidate set only because they are so highly expressed that 
they become statistically significant.  For graphical presentation and discussion, the 
metric p2 - p1 quantifies the parent-or-origin effect in the range from -1 to +1. If there 
is no parent-of-origin effect, then p2 - p1 = 0. If there is preferential expression of the 
paternal allele, then p2 - p1 > 0. If there is preferential expression of the maternal allele, 
then p2 - p1 < 0.  In order to keep the false positive rate low, we only include 
candidate genes with two or more informative SNPs.  
 
Verification of the candidate imprinted genes with allele-specific pyrosequencing 
We selected three known imprinted genes (Igf2, Peg10 and Klf14) and seven candidate 
imprinted genes (Pde10a, Phf17, Gpsm2, Zfp64, Htra3, Phactr2 and Trim23) for 
allele-specific expression quantification using Pyrosequencing.  To exclude the 
possibility of stochastic expression effects and sex-specific genomic imprinting, we 
verified these genes in placentas harboring 3 female and 1 male F1 progeny from each 
of AKR-PWD reciprocal crosses. To exclude strain-specific effects, 3 novel imprinted 
genes (Pde10a, Phf17 and Phactr2) were verified in an additional 3 female and 1 male 
progeny bearing placentas from each of B6-CAST reciprocal crosses. The 
pyrosequencing assay design and sequencing protocol can be found in (Wang et al. 
2010).  
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Results 
 
mRNA-seq alignments, transcriptome coverage and SNP calling  
This mRNA-seq study was performed on E17.5 placental tissues from reciprocal 
crosses of AKR and PWD mouse strains. We obtained 66 million 44-bp reads from 
placenta cDNA of a single AKR x PWD F1 individual and 63 million reads from the 
reciprocal PWD x AKR placental transcriptome.  60% of the reads could be uniquely 
mapped to the NCBI B37 mouse reference genome, with 55.2% of reads mapping to 
the exons and 4.8% mapping to the exon-intron junctions. The total expression levels 
were quantified by RPKM, which is a normalized per gene read counts (Mortazavi et 
al. 2008). In the RNA-seq data, there was coverage of 12,532 Ensembl unique genes 
(41,110 transcripts) with RPKM greater than 1, and 6,794 unique genes had an RPKM 
value greater than 5.  
 
Informative SNP positions are needed to quantify the allele-specific expression. From 
de novo SNP calling based on the RNA-seq data, after quality filtering, we found 
43,510 high-quality autosomal SNPs, 96.4% of which reside in known Ensembl gene 
models. To remove the genome mapping bias, we summarized the SNP counts by the 
average count when mapped to the reference genome and to a pseudo-genome of the 
alternate strain (See Materials and Methods).  
 
Detection of significant parent-of-origin effects  
With the read counts at the informative SNP positions, we were able to determine the 
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allele-specific expression ratio from the relative counts of the reference and alternative 
alleles (Wang et al. 2008). We define p1 as the expression percentage from the AKR 
allele in placentas from the AKR female x PWD male cross and p2 as the AKR allele 
percentage in the reciprocal cross. In regard to the direction of transmission, p1 is the 
maternal allele percentage in AKR x PWD, and p2 is the paternal percentage for PWD 
x AKR. The Storer-Kim test was used as a formal statistical test of the null hypothesis 
that (p2 - p1) = 0. Rejections of this null hypothesis identify novel imprinted candidate 
genes (See Materials and Methods). To further filter the data and reduce false 
positives, rather than relying only on the P-value of the Storer-Kim test, we also used 
an arbitrary cut-off of p1 > 0.65 and p2 < 0.35 for maternally expressed candidates, and 
p1 < 0.35 and p2 > 0.65 for paternally expressed ones.  This allows for identification 
of partially imprinted genes when there are sufficiently many reads spanning the SNPs 
to make a confident call. 
 
Out of the 5,557 unique genes covered with two or more informative SNPs, with the 
above criteria for significant parent-of-origin effect identification, we found 251 
significant candidates with q-value < 0.01 and SNP coverage 4 or more in each of the 
two reciprocal crosses (criterion 1). Of these candidate genes, 120 have preferential 
maternal expression, and 131 have a paternally biased expression. If we use RPKM>1 
and SNP coverage>10 in both reciprocal crosses as the criteria for inclusion, 216 
significant candidates are left, with 115 paternal and 101 maternal candidates 
(criterion 2). If we use a more stringent cut-off of PRKM>3 and SNP coverage>20, 
only 113 candidates are retained, with 60 paternal and 53 maternal candidates 
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(criterion 3). To visualize the allelic expression ratio and the degree of parent-or-origin 
effect genome-wide, we made a plot for each autosome, and chromosome 7 is shown 
in (Figure 35) as an example. From these figures, we observed that most of the genes 
show nearly 50:50 allelic expression ratios, when we scan along the chromosomes.  
A number of significant candidate imprinted genes emerged from the parent-of-origin 
effect plot.  
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Figure 35. Allele-specific expression ratio and the distribution along mouse 
chromosome 7 of parent-of-origin biased expression. Left panel:  Allele-
specific expression levels for genes on chromosome 7 for both AKR female x 
PWD male and PWD female x AKR male F1 fetal tissue from the placentas. 
The x-axis is the allelic expression ratio from the AKR allele (0% to 100%) in 
the two reciprocal crosses. The y-axis is the physical location along the 
chromosome. The red bar is drawn according to the AKR allelic expression 
ratio (p1) in the AKR x PWD cross, and the blue bar is the AKR allelic 
expression ratio (p2) in the PWD x AKR cross (throughout we adhere to the 
convention of listing crosses as female x male).  Right panel:  Degree of 
parent-of-origin effect on chromosome 7. Unique Ensembl genes covered with 
a high-quality SNP count of at least 4 in each of the two reciprocal crosses are 
included in the plot. The height of each bar is the degree of the parent-of-
origin effect, which is computed as (p2-p1). The blue and red colors represent 
significant candidate imprinted genes with RPKM > 3 and q-value < 0.01. The 
gene name is displayed for the significant, known imprinted genes and 
candidate genes with | p2-p1| > 0.4.  
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Significant candidate imprinted genes that are previously known to be imprinted 
in mouse  
Among the 251 candidate imprinted genes that we identified from criterion 1, 35 have 
been previously reported in the mouse literature to be imprinted. For each gene, the 
number of SNPs, total SNP counts, allelic expression ratios and the q-value are 
summarized in Table 1. We compared the expression direction of these genes in our 
RNA-seq data and the previously reported imprinting direction, and 35 out of 35 
matched. 23 of the 35 genes were known to be imprinted in mouse placenta in various 
stages and crosses: Igf2 (DeChiara et al. 1991; Hu et al. 1995), Peg10 (Ono et al. 
2003), Sfmbt2 (Kuzmin et al. 2008), Sgce (Piras et al. 2000), Plagl1 (Piras et al. 2000; 
Smith et al. 2002), Slc38a4 (Mizuno et al. 2002; Smith et al. 2003), Airn (also known 
as Igf2rAS) (Wutz et al. 1997) , Rtl1 (Seitz et al. 2003), Mest (Kaneko-Ishino et al. 
1995), Igf2as (Moore et al. 1997) and Dlk1(Schmidt et al. 2000) are known to be 
paternally expressed in the mouse placenta; H19 (Bartolomei et al. 1991), Igf2r 
(Barlow et al. 1991), Cdkn1c (Hatada and Mukai 1995), Grb10 (Miyoshi et al. 1998), 
Ppp1r9a (Ono et al. 2003), Klf14 (Parker-Katiraee et al. 2007), Nesp (Peters et al. 
1999), H13 (Wood et al. 2007), Slc22a2 (Zwart et al. 2001), Asb4 (Mizuno et al. 
2002), Slc22a18 (Dao et al. 1998) and Kcnq1(Gould and Pfeifer 1998) are 
preferentially expressed from the maternal allele. The remaining 12 genes are either 
known to be not imprinted in the placenta or the imprinting status in the placenta is not 
clear. In this study, we found that they are actually imprinted in E17.5 mouse placenta 
in AKR-PWD reciprocal crosses. Peg3 (Kaneko-Ishino et al. 1995) is known to be 
imprinted in the human placenta (Hiby et al. 2001), however, the imprinting status in 
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the mouse placenta had not been reported. Ndn (MacDonald and Wevrick 1997) and 
Magel2 (Boccaccio et al. 1999) are both expressed in the mouse placenta, whereas the 
imprinting status was not clear. Rian (Hatada et al. 2001), Zim1 (Kim et al. 1999), 
Meg3 (Miyoshi et al. 2000), Mirg (Seitz et al. 2004), Usp29 (Kim et al. 2000), Impact 
(Hagiwara et al. 1997), Nnat (Kagitani et al. 1997), Zdbf2 (Kobayashi et al. 2009) and 
Zrsr1 (Hatada et al. 1993) were not previously reported to be imprinted in the mouse 
placenta either. Therefore, we identified 12 candidate genes with novel mouse 
placenta imprinting status.  
 
The q-value rank order is presented in (Table 19). We noticed that most of the known 
imprinted genes identified in our study have higher q-value rank relative to other 
genes, most of them are highly expressed in the placenta, and the imprinting status of 
most previously known imprinted genes is close to 100%.  We conclude that most of 
the significant imprinted genes with highest degree of parent-of-origin bias have 
already been identified by the genomic imprinting community. The high concordance 
(35 out of 35) of known imprinted genes with the significance of our test of parent-of-
origin effects on allelic expression ratios provides one measure of the confidence in 
the results despite the lack of replication at the RNA-seq stage.     
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Table 19. Imprinted genes identified in mouse placenta RNA-seq data that have been 
reported previously in the literature. 
AKR PWD AKR PWD
1 Igf2 3 2 2235 4418 0 0.09% 100.00% 0 P P YES
2 Peg10 13 9.5 3503 17293 3 0.27% 99.98% 0 P P YES
3 Sfmbt2 13 5 555 761.5 15 0.89% 98.07% 0 P P YES
4 Peg3 11 202 4944 6398 1 3.93% 99.98% 0 P P NO
5 Rian 31 1180 38 104.5 2080 96.88% 4.78% 0 M M NO
6 H19 2 2067 0 59.5 9319 100.00% 0.63% 0 M M YES
7 Zim1 10 1600 0 52.5 2365 100.00% 2.17% 0 M M NO
8 Meg3 26 866.5 0 52 1610 100.00% 3.13% 0 M M NO
9 Igf2r 11 482 0 57 1785 100.00% 3.10% 0 M M YES
10 Cdkn1c 1 468.5 0 26 671 100.00% 3.73% 5.3E-294 M M YES
11 Sgce 4 51 523 499 22.5 8.89% 95.69% 1.1E-213 P P YES
12 Plagl1 4 0 210 616.5 0 0.00% 100.00% 6.9E-200 P P YES
13 Grb10 10 846 148 972 1999 85.15% 32.72% 1.3E-189 M M YES
14 Slc38a4 2 18 250 439 0 6.73% 100.00% 2.3E-168 P P YES
16 Mirg 9 160 0 12 313.5 100.00% 3.69% 3.1E-111 M M NO
17 Usp29 1 0 94 128.5 0 0.00% 100.00% 8.08E-63 P P NO
18 Impact 2 6 89 293 16 6.32% 94.82% 2.71E-62 P P NO
20 Airn 6 0 75.5 158.5 0 0.00% 100.00% 3.22E-61 P P YES
21 Rtl1 5 12 145 154 13 7.64% 92.22% 4.37E-58 P P YES
22 Ppp1r9a 6 76 0 23.5 162.5 100.00% 12.63% 7.62E-43 M M YES
23 Mest 1 0 38.5 108.5 0 0.00% 100.00% 9.54E-34 P P YES
24 Nnat 2 0 37 147 5 0.00% 96.71% 4.63E-32 P P NO
28 Zdbf2 5 0 86 85.5 46 0.00% 65.02% 9.08E-25 P P NO
33 Klf14 3 54.5 6 6 55 90.08% 9.84% 1.43E-18 M M YES
34 Nesp 1 34.5 0 3 46 100.00% 6.12% 3.03E-18 M M YES
35 H13 2 152.5 74.5 118 282 67.18% 29.50% 5.36E-18 M M YES
38 Zrsr1 1 0 19 67.5 0 0.00% 100.00% 1.16E-17 P P NO
56 Slc22a2 2 22 0 2 40 100.00% 4.76% 1.51E-13 M M YES
80 Asb4 4 65 27 5 47 70.65% 9.62% 1.23E-11 M M YES
98 Ndn 1 0 28.5 13 0 0.00% 100.00% 1.22E-09 P P NO
121 Igf2as 1 0 41.5 7.5 0.5 0.00% 93.75% 2.99E-08 P P YES
167 Slc22a18 1 12 0 20 59.5 100.00% 25.16% 5.3E-06 M M YES
176 Magel2 1 1 17.5 16.5 3 5.41% 84.62% 1.01E-05 P P NO
180 Kcnq1 1 6 0 0 23 100.00% 0.00% 1.53E-05 M M YES
189 Dlk1 1 0 7 14 0 0.00% 100.00% 5.08E-05 P P YES
p1q-value 
ranking
Gene 
name
# of 
SNPs
AKRxPWD 
allele counts
PWDxAKR 
allele counts p2 qvalue Expr. 
allele
Known 
expr. 
allele
Known in 
mouse 
placenta?
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Identification and verification of novel imprinted genes in the mouse placenta 
To confirm the novel imprinted candidates identified above, we need to quantify their 
allele-specific expression using an independent method. We performed 
pyrosequencing to quantify allele-specific expression in two reciprocal F1 placenta 
samples. Pyrosequencing is a highly quantitative method to profile the allelic 
expression ratio, with a measurement coefficient of variation of 2-5% (Marsh 2007). 
To exclude the possibility of random monoallelic expression for specific genes 
(Lomvardas et al. 2006; Gimelbrant et al. 2007), and potential sex-specific imprinting 
status (Gregg et al. 2010a), we verified the candidates in 4 AKR x PWD F1 
individuals (3 females and 1 male) and 4 PWD x AKR F1 individuals (3 females and 1 
male). The average allelic percentage is reported in (Table 20).  
 
We selected a total of 10 candidate genes for verification, including three known 
imprinted genes as positive controls (Igf2, Peg10 and Klf14). Among the top 20 
candidates, only 2 are novel (Pde10a and Phf17), and we included both. Then we 
selected 5 additional novel candidates (Gpsm2, Zfp64, Htra3, Trim23 and Phactr2) for 
verification (Table 21).  
 
From the pyrosequencing results in Table 21, 8 of the 10 known and novel candidate 
genes we tested are verified to be imprinted; one candidate gene (Trim23) did not 
show good pyrosequencing signal due to low expression level; we observed biallelic 
expression for one candidate gene (Gspm2). Further examination of the Gspm2 gene 
region reveals that the different SNPs are not consistent in RNA-seq data.  Careful 
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inspection of the RNA-seq read alignments suggests that the false-positive call may 
have been made because of poor read mapping, as the read depth is unusually variable 
around this gene.  Therefore, we have an empirical false discovery rate of 1 out of 9 
or 11% confirmed by our pyrosequencing verification results.   
 
Igf2 and Peg10 were correctly verified as paternally expressed imprinted genes, and 
Klf14 as maternally expressed imprinting gene, which is consistent with the results in 
our RNA-seq data. Among the 7 novel candidates, 5 (Pde10a, Phf17, Zfp64, Htra3 
and Phactr2) were verified to be novel imprinted genes in the mouse placenta (Table 
20), one test failed due to low expression, and one failed to validate.  
 
Pde10a is the most significant novel candidate gene (q-value rank 15). It is located on 
chromosome 17, 3.6 Mbp away from the known imprinted gene, Slc22a3. It is a 
member of the phosphohydrolyase gene family, catalyzing the hydrolysis of the cAMP 
and cGMP to the respective nucleoside 5’ monophosphate (Loughney et al. 1999; 
Soderling et al. 1999). Pyrosequencing primers were designed to target one of the 12 
significant SNPs in this gene (Figure 36A). In the RNA-seq data, we observed 
expression primarily from the maternal allele in both AKR-PWD reciprocal crosses 
(Figure 36B). We verified it in four placentas from each of the two reciprocal crosses, 
and we found consistent preferential maternal expression (Figure 36C, D). To exclude 
the possibility of strain-specific imprinting, we also tested placenta tissue from B6-
CAST reciprocal crosses, and we obtained the same results (Table 22). Thus, we 
conclude that Pde10a is a novel imprinted gene in the E17.5 placenta.  
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Table 20. Pyrosequencing verification for known/novel imprinted genes in 
mouse placenta. 
p 1 p 2
RNA-seq RNA-seq
1 Igf2 0.09% 100.00% P 6.10% 100.00% Confirmed 
known
P
2 Peg10 0.27% 99.98% P 0.00% 100.00% Confirmed 
known
P
15 Pde10a 93.27% 8.40% M 77.40% 14.83% Novel M
19 Phf17 18.72% 71.39% P 40.29% 75.26% Novel P
25 Gpsm2 0.00% 96.04% P 64.20% 63.75% Not 
imprinted
Biallelic inconsistent 
SNPs
26 Zfp64 18.44% 75.95% P 28.41% 100.00% Novel P
33 Klf14 90.08% 9.84% M 91.15% 0.00% Confirmed 
known
M
40 Htra3 100.00% 4.00% M 73.55% 43.69% Novel M low expression 
level
47 Trim23 0.00% 100.00% P - - No signal -
low expression 
level
145 Phactr2 66.79% 34.81% M 62.32% 30.94% Novel M
Preferentially 
expressed 
allele
Notes
q -value 
ranking
Gene 
name
Expr. 
allele in 
RNA-
seq
p 1  pyro 
AKR x PWD
p 2  pyro 
PWD x AKR
Conclusion
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Table 21. RNA-seq read-counts summary for selected known/novel imprinted 
genes for verification in mouse placenta. 
AKR PWD AKR PWD
1 Igf2 3 2 2235 4418 0 0.09% 100.00% 0 P 1109.87 974.25
2 Peg10 13 9.5 3503 17293 3 0.27% 99.98% 0 P 1500.91 1031.52
15 Pde10a 12 347 25 44 480 93.27% 8.40% 1.24E-159 M 14.14 13.22
19 Phf17 7 64.5 280 584 234 18.72% 71.39% 1.80E-61 P 25.85 37.61
25 Gpsm2 2 0 59 48.5 2 0.00% 96.04% 7.30E-27 P 3.49 2.94
26 Zfp64 5 33 146 120 38 18.44% 75.95% 3.04E-25 P 11.72 6.78
33 Klf14 3 54.5 6 6 55 90.08% 9.84% 1.43E-18 M 4.37 3.27
40 Htra3 3 53 0 1 24 100.00% 4.00% 2.47E-17 M 0.72 0.52
47 Trim23 2 0 32 26 0 0.00% 100.00% 2.60E-15 P 1.68 1.96
145 Phactr2 6 87.5 43.5 59 111 66.79% 34.81% 5.04E-07 M 8.07 11.26
p 1
q -value 
ranking
Gene 
name
# of 
SNPs
AKR x PWD 
allele counts
PWD x AKR 
allele counts p 2 q -value
Expr. 
allele
Expr. level 
AKR x PWD
Expr. level 
PWD x AKR
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Table 22. Pyrosequencing verification results table in AKR-PWD and B6-
CAST reciprocal crosses (percent of AKR/B6 allele is shown in the table).  
SampleID Sex Mother Father Igf2 Peg10 Klf14 _1* Klf14 _2 Htra3 _1 Htra3 _2 Gpsm2
AKR/PWD allele C/T G/A C/T C/T A/G A/G G/A
AP1 Male AKR PWD 7.00% 0.00% 93.50% 97.10% 70.60% 72.70% 62.90%
AP2 Female AKR PWD 5.90% 0.00% 78.20% 90.80% 96.00% 95.80% 64.50%
AP3 Female AKR PWD 5.80% 0.00% 89.50% 98.90% 61.80% 65.80% 64.80%
AP4 Female AKR PWD 5.70% 0.00% 96.60% 84.60% 61.50% 64.20% 64.60%
PA1 Male PWD AKR 100.00% 100.00% 0.00% 0.00% 46.20% 47.20% 63.70%
PA2 Female PWD AKR 100.00% 100.00% 0.00% 0.00% 37.70% 42.30% 64.40%
PA3 Female PWD AKR 100.00% 100.00% 0.00% 0.00% 42.70% 43.30% 64.80%
PA4 Female PWD AKR 100.00% 100.00% 0.00% 0.00% 46.10% 44.00% 62.10%
SampleID Sex Mother Father Zfp64 _1 Zfp64 _2 Phf17 _1 Phf17 _2 Pde10a Phactr2 _1 Phactr2 _2
AKR/PWD allele G/A G/A C/T C/T T/C C/T C/T
AP1 Male AKR PWD 34.70% 35.10% 43.00% 40.30% 78.00% 57.30% 64.60%
AP2 Female AKR PWD 0.00% 0.00% 43.40% 42.20% 78.40% NA 58.70%
AP3 Female AKR PWD 39.60% 37.60% 41.90% 40.50% 71.60% 63.20% 66.20%
AP4 Female AKR PWD 40.00% 40.30% 35.60% 35.40% 81.60% NA 63.90%
PA1 Male PWD AKR 100.00% 100.00% 85.00% 75.50% 23.70% 29.60% 26.00%
PA2 Female PWD AKR NA NA 72.30% 71.60% 17.40% NA 29.40%
PA3 Female PWD AKR 100.00% 100.00% 73.90% 71.10% 0.00% 33.60% 33.40%
PA4 Female PWD AKR NA NA 77.10% 75.60% 18.20% 32.90% 31.70%
SampleID Sex Mother Father Phf17 _1 Phf17 _2 Pde10a _1 Pde10a _2 Phactr2 _1 Phactr2 _2
B6/CAST allele C/T C/T T/C T/C C/T C/T
BC1 Male C57BL/6 CAST 43.20% 41.50% NA 23.20% 23.60% 20.30%
BC2 Female C57BL/6 CAST 38.70% 37.80% NA 23.40% 26.00% 31.60%
BC3 Female C57BL/6 CAST 42.30% 40.30% NA 0.00% 28.00% 27.10%
BC4 Female C57BL/6 CAST 45.70% 44.20% NA 22.20% 26.80% 30.40%
CB1 Male CAST C57BL/6 77.30% 75.40% 71.80% 65.50% 50.10% 52.00%
CB2 Female CAST C57BL/6 74.30% 74.40% NA 62.60% 57.40% 52.70%
CB3 Female CAST C57BL/6 74.80% 74.30% 63.80% 68.30% 55.80% 51.80%
CB4 Female CAST C57BL/6 76.10% 76.70% 61.90% 55.50% 57.10% 52.30%
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Figure 36. Verification of the novel candidate imprinted gene Pde10a, a 
preferentially maternally-expressed imprinted gene.  
(A). The mouse crossing scheme used to generate the AKR-PWD reciprocal 
F1 placentas. One informative SNP within the gene is shown in the Figure with 
a T allele in AKR and a C allele in PWD.  
(B). SNP allelic counts summary table for the Pde10a gene, showing 
preferential maternal expression.   
(C). Pyrograms for verification in 4 individuals of AKR x PWD cross (1 male 
and 3 females). Target sequence analyzed: AA(C/T)GTTTTCTT.  
(D). Pyrograms for verification in 4 individuals of PWD x AKR cross (1 male 
and 3 females). 
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Phf17 is the second most significant novel candidate in the list. It is located on mouse 
chromosome 4 and it is not near any of the known imprinting cluster. Phf17 (aka 
Jade1) is a component of the HBO1 complex which has a histone H4-specific 
acetyltransferase activity and performs most of the histone H4 acetylation in vivo (Foy 
et al. 2008). Imprinting of genes involved in histone modifications are particularly 
interesting, as they may provide a means for amplification of the imprinting signal, 
and for propagating the effect to other target genes.  Pyrosequencing verifications 
confirmed preferential paternal expression in both AKR-PWD and B6-CAST crosses 
(Table 20 and Table 22).   
 
Phactr2 is a phosphatase and actin regulator, and it is identified in our RNA-seq study 
as a maternally expressed imprinted candidate. This gene had not previously been 
known to be imprinted in mouse. We verified it in multiple individuals of both AKR-
PWD and B6-CAST crosses, and it is confirmed to be preferentially expressed from 
the maternal allele (Table 20 and Table 22). In a recent Illumina ASE BeadArray 
survey of novel imprinted genes in human term placenta, human PHACTR2 is found 
to be partially imprinted, with a maternal allelic bias (Daelemans et al. 2010). 
Therefore, the imprinting status of Phactr2 is conserved between mouse and human.  
Phactr2 is on mouse chromosome 10, 104 kbp downstream of a paternally expressed 
known imprinted gene, Plagl1. Phactr2 is transcribed in the opposite direction to 
Plagl1, which could be another reciprocally-imprinted sense-antisense pair (Wang et 
al. 2008).  
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Among the 7 novel candidates tested, two other genes, Zfp64 and Htra3 have also 
been verified to be partially imprinted in the mouse placenta. Zfp64 is on mouse 
chromosome 2, 6 Mbps from a known imprinted gene Nesp. Zfp64 is a Krüppel family 
transcription factor that is under the control of Runx2, and participates in Notch 
signalling to regulate differentiation in mesenchymal cells (Sakamoto et al. 2008). 
Htra3 is a serine protease whose activity is absolutely required for its activity in TGF-
beta signalling inhibition (Tocharus et al. 2004).  Htra3 was initially discovered to 
have a strong 100%:0% allelic bias, but the verification results showed only partial 
imprinting (with a 75%:25% allelic bias). This could be due to the low expression 
level of Htra3 in the mouse placenta (RPKM < 1).   
 
Finally, considering the last two imprinting validation tests, the pyrosequencing signal 
from Trim23 was too low to determine the allelic expression percentage. Therefore we 
could neither confirm nor exclude the imprinting status of Trim23. Gpsm2 was shown 
in our pyrosequencing assay to be not imprinted in the mouse placenta (Table 20). 
Overall the empirical verification rate is quite high (8 out of 9 successful tests), 
compared to other recently published transcriptome-wide surveys.  
 
Assessment of the degree of maternal contamination in our placenta samples 
One caution about identifying novel imprinted genes in the mouse and human placenta 
is the potential for maternal contamination (Proudhon and Bourc'his 2010). The 
placenta is a complex organ that consists of many different tissue and cell types. For 
term and near-term placenta, the contact of maternal and fetal tissues at the interface is 
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challenging to separate by dissection, resulting in the potential for maternal 
contamination (Proudhon and Bourc'his 2010). In some studies of novel imprinted 
genes in the placenta, the possibility for maternal contamination cannot be excluded.  
 
Several approaches were used to minimize maternal contamination in our samples. 
The first was to take special precautions during the dissection. From every sample 
collected, tissue was only taken from the middle of the placenta and only from what 
was clearly the fetal side. Then we washed the tissue many times in PBS to remove 
maternal blood. Second, we quantified the degree of contamination and chose the 
samples for RNA-seq that had the least maternal contamination (based on allelic 
expression ratio of several known imprinted genes with 100% paternal expression in 
placenta). If there were maternal contamination, paternally expressed imprinted genes 
would display expression from the maternal allele, and the degree of leakage could be 
used as a criterion to select the best samples. Third, several uterus samples near the 
placenta were collected at the same time, which allowed us to check the uterus 
expression level of a gene to determine the potential for contamination. Fourth, with 
the transcriptome-wide allelic expression profile, maternal contamination would be 
reflected by an allelic bias throughout the genome. By quantifying read counts of 
maternal alleles transcriptome-wide, it has been possible to estimate the degree of 
maternal contamination, and use this estimate to normalize SNP counts in the 
candidate imprinted genes.   
 
Before we quantify the maternal bias introduced by maternal tissue contamination, we 
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need to understand what other factors could also contribute to the deviation from 
50:50 expression ratio of the two parental alleles. First, there is the possibility of 
global eQTL effects. As we observed from the allelic expression from a single gene, 
not all genes show 50:50 ratios.  If the AKR allele is associated with a cis-regulatory 
element, it could have higher expression from AKR allele in both reciprocal crosses. If 
we sum the SNP counts over all genes, it should be close to 50:50.  Second, since we 
are aligning reads with both the AKR and PWD sequences to the B6 reference 
genome, there will be a mapping bias toward the AKR allele, because the mouse strain 
genealogy shows that the AKR strain is closer to the B6 strain. So it was important to 
quantify and remove the mapping bias before we could assess the degree of maternal 
contamination (See Materials and Methods). Finally, imprinted X inactivation takes 
place in the mouse placenta, which means that the X-linked genes in females will be 
primarily expressed from the maternal allele (Sado and Ferguson-Smith 2005). If a 
gene/SNP has X chromosome homology, the reads might actually be from the X 
chromosome, which would create a spurious maternal bias. Consequently, in this 
analysis the X chromosomal genes were not assessed for imprinting status. 
 
To illustrate these confounding factors for the deviation from 50:50 allelic expression, 
we present an example in (Table 23). Under a null model, if there is not any global 
eQTL effect or maternal bias or mapping bias, the allelic expression ratio will be 
50:50 in both AKR x PWD and PWD x AKR crosses. Suppose there is 5% mapping 
bias. We would then always observe 55% expression from the AKR allele in both 
reciprocal crosses. If there is 5% maternal contamination, we would detect 55% 
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expression of the AKR allele in the AKR x PWD cross, because AKR is the mother in 
this cross, but 45% expression of the AKR allele in the PWD x AKR cross because 
PWD is the mother (Table 23). To quantify the degree of maternal contamination, we 
compute (p1_overall – p2_overall)/2 as an metric whose expectation is zero if there is no 
maternal contamination (where p1_overall is the total AKR allelic expression percentage 
from the AKR x PWD cross summing over all genes in the transcriptome, and p2_overall 
is the total AKR expression percentage from the PWD x AKR cross, again summing 
over the transcriptome). With this metric, eQTL effects will cancel out, leaving a bias 
for un-imprinted genes only if there is maternal contamination.  
 
In our placenta data, the total AKR allelic percentages are 51.99% and 51.52% in the 
AKR x PWD and PWD x AKR crosses respectively, before correcting the alignment 
bias (Table 23). After the mapping bias correction, the percentages are 50.50% and 
50.17%, indicating that there is roughly a 1.5% mapping bias (Table 23). The maternal 
contamination is estimated to be 0.15% (Table 23), a quite tolerably low figure.  For 
genes with moderate and high expression levels in our placenta samples, the effect of 
maternal contamination was negligible.  
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Table 23. Quantification of global maternal contamination percentage. 
NO NO YES
NO YES NO before after
AKR(mat) % 50% 55% 55% 51.99% 50.50% 50.49%
PWD(pat)% 50% 45% 45% 48.01% 49.50% 49.51%
AKR(pat) % 50% 55% 45% 51.52% 50.17% 50.18%
PWD(mat)% 50% 45% 55% 48.48% 49.83% 49.82%
0.17% 0.15%0% 5%
Expected (5% 
maternal/mapping bias) Observed total allelic %
Maternal contamination mapping bias 
correction
after removal 
of SNPs with X‐
homology Strain mapping bias
 maternal contamination
AKR x PWD
PWD x AKR
Quantification of
0% ‐
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Maternally expressed placenta-only imprinted genes: artifacts of maternal 
contamination?  
Because of the maternal contamination problem, the imprinting status has been 
questioned for 13 placenta-only known imprinted genes (Proudhon and Bourc'his 
2010). All are known to be maternally expressed imprinted genes. Among these genes, 
Gatm, Pon3, Th, Tspan32, Cd81, Tssc4, Tnfrsf23 and Osbpl5 have sufficient SNP 
coverage in our data to determine the imprinting status with confidence (Table 24). 
The genes, Tfpi2, Pon2 and Dcn, do not show significant parent-of-origin effect in our 
data, suggesting that they may not be imprinted, at least at stage E17.5 in the AKR-
PWD strain combination (Table 24). Ppp1r9a is detected to be imprinted with 
preferential maternal expression. Nap1l4 is discovered to be a maternally expressed 
imprinted gene in the placenta (Engemann et al. 2000). Others have suggested that 
there may be leaky expression from the paternal allele (Umlauf et al. 2004). When we 
examined this gene in detail, we found four SNPs in the gene region, two in the exons 
and two in the introns. One exonic SNP shows biallelic expression, and the other one 
shows preferentially maternal expression (Table 25). The parent-of-origin effect is not 
significant if we sum over the two SNPs (Table 24). There are also two SNPs covered 
by the Illumina reads in the intron, with preferential paternal expression (Table 25). 
This gene maybe imprinted and there might be antisense non-coding transcript in the 
intronic region, or there may be complications from alternative splice products. 
Further investigation is needed to determine the imprinting status of Nap1l4. 
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Table 24. Coverage of known placenta-only imprinted genes whose imprinting 
status has been questioned. 
AKR PWD AKR PWD
Gatm Prox2 M - - - - - - -
Not enough 
SNP coverage
Tfpi2 Prox6 M 0 8 4 8 0.00% 33.33% 0.16215 Not imprinted*
Ppp1r9a Prox6 M 76 0 23.5 163 100.00% 12.63% 7.60E-43 Imprinted
Pon3 Prox6 M - - - - - -
Not enough 
SNP coverage
Pon2 Prox6 M 35.5 38 55 106 48.30% 34.16% 0.07218 Not imprinted
Th Dist7 M - - - - - - -
Not enough 
SNP coverage
Tspan32 Dist7 M - - - - - - -
Not enough 
SNP coverage
Cd81 Dist7 M - - - - - - -
Not enough 
SNP coverage
Tssc4 Dist7 M - - - - - - -
Not enough 
SNP coverage
Nap1l4 Dist7 M 7 14.5 29 22 32.56% 56.86% 0.16468
could be 
imprinted
Tnfrsf23 Dist7 M - - - - - - -
Not enough 
SNP coverage
Osbpl5 Dist7 M - - - - - - -
Not enough 
SNP coverage
Dcn Dist10 M 130 29 284 123 81.76% 69.83% 0.01028 Not imprinted
q -value ConclusionGene name
Mouse 
chr
Expr. 
allele
AKR x PWD 
allele counts
PWD x AKR 
allele counts
p 1 p 2
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Table 25. Allelic expression ratios for SNPs in Nap1l4 gene region. 
AKR PWD AKR PWD
chr7 150700360 7 6 20 19 53.85% 51.28% 1 Biallelic exonic ENSMUSE00000498169
chr7 150701525 9.5 0 15 16 100.00% 48.39% 0.0096 P intron NA
chr7 150707592 32 8 0 5 80.00% 0.00% 0.0039 P intron NA
chr7 150734989 0 8.5 9 3 0.00% 75.00% 0.0048 M exonic ENSMUSE00000667974
qvalue Direction
SNP 
type Conclusion
Mourse 
chr
SNP 
position
AKRxPWD 
allele counts
PWDxAKR 
allele counts p1 p2
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Maternal contamination could not only create false positive calls for maternally 
expressed imprinted genes, but also may result in a paternally expressed imprinted 
gene to be a false negative. Zdbf2 could be one of such example. Zdbf2 is detected in 
our data to be imprinted with preferential paternal expression, but it has been 
previously reported to be biallelically expressed in the placenta (Kobayashi et al. 
2009). However, this could also be due to a different imprinting status of the same 
gene in different developmental stages/mouse strain combinations.  
 
Is there a bias toward more maternally expressed imprinted genes in the 
placenta?  
Contrasting patterns of genomic imprinting in the brain and placenta raises a series of 
questions about the mechanism and evolution of the control of imprinting. Previously, 
in a literature review of the tissue specificity and maternal vs. paternal expression of 
imprinted genes (Morison et al. 2005), it was noted that there is a paternal-
brain/maternal placenta bias (Wang et al. 2008; Proudhon and Bourc'his 2010). The 
genes imprinted in the brain but not the placenta tend to be paternally expressed, 
whereas the genes imprinted in the placenta but not the brain tend to be maternally 
expressed (Figure 37A and Table 26) (P-value = 0.0001322, Fisher’s exact test). Our 
previous study also provided some suggestive evidence that the brain-paternal bias 
might be real (Wang et al. 2008).  Here, we would like to ask whether the maternal-
placenta bias is also true, or whether there might be an artifact due to the potential 
maternal contamination or limited sampling. We covered 35 known imprinted genes 
and verified 5 additional novel imprinted genes in this study. If we break them down 
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by the direction of imprinting, we do not see a bias toward more maternally expressed 
genes (Figure 37B) (P-value = 0.6821, one-sided exact binomial test). If we examine 
all 251 candidates and classify them by their expression bias, we still see roughly 
equal numbers of paternally and maternally expressed candidates (Figure 37C), and 
the degree of allelic bias is statistically homogeneous between the two sets of 
reciprocal offspring.     
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Table 26. Tissue of imprinted genes and the imprinting direction. 
Class of selected genes Count Gene names
Genes imprinted in brain but 
NOT placenta 19
Nnat (peg5), Copg2, Nap1l5, Peg3, Usp29, Zfp264, Peg12 
(Frat3), Mkrn3 (Zfp127), Magel2, Ndn, Snurf-Snrpn, 
Inpp5f_v2, Rasgrf1, Impact, Zdbf2,  Calcr, Ube3a, 
Commd1, Kcnk9
Genes imprinted in placenta 
but NOT brain
16
Sfmbt2, Dlk1 (Peg9),  Nesp, Gatm, Ascl2 (Mash2), 
Phemx (Tssc6), Tssc4, Slc22a18, Phlda2 (Tdag51), 
Nap1l4, Tnfrsf23, Osbpl5, Dcn, Grb10 (Meg1), Slc22a2, 
Slc22a3
Genes imprinted in both 
brain and placenta 9
Sgce, Peg10,  Igf2, Plagl1, Rtl1(Peg11), Slc38a4, Asb4, 
Klf14, H13
Other* 13
Gnasxl, Mest (Peg1), Ins2, Dio3,  Gnas, Zim1, Zim2, 
Zim3, Cd81 (Impt1), Kcnq1, Cdkn1c (p57KIP2), Htr2a, 
Igf2r
Total 57
*This category is genes that are imprinted in other tissues (not brain and placenta).  
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Figure 37. Paternal vs. maternal novel and candidate imprinted genes.  
(A). Paternal vs. maternal imprinting status in brain and placenta in the 
literature.  
(B). The number of paternally and maternally expressed known and novel 
imprinted genes in our study.  
(C). The number of paternally and maternally expressed candidate imprinted 
genes identified in our study. 
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Discussion 
 
The number of imprinted genes in the mouse genome 
Different studies present quite a wide range of estimates of the number of imprinted 
genes in the mouse genome, ranging from 100 genes (Luedi et al. 2007), to 600 genes 
(Luedi et al. 2005), to 1,300 genes (Gregg et al. 2010b), to 2,000 genes (Nikaido et al. 
2003). There are several reasons for the broad range of these estimates. First, different 
studies used widely varying approaches, so they will have different false positive rates 
as well as different coverage and sensitivity. Second, different studies examined 
different tissues and developmental stages. In our study, we found 251 candidate 
imprinted genes in the E17.5 placenta falling in the set with a statistical false 
discovery rate of 0.01, but we also show empirically that the false discovery rate is 
more like 11%. Most of the top genes in the list are already known to be imprinted, 
indicating that the genomic imprinting community has done a commendable job of 
identification of the imprinted genes.  Exhaustive enumeration of imprinted genes 
will require a large community-wide effort, including multiple replicates from 
multiple lines, with samples of many tissues and many developmental time points.  If 
the results are to be interpreted with confidence based on RNA-seq data alone, a 
blocked and replicated design is essential (Auer and Doerge 2010). 
 
Our intention here was to apply RNA-seq in a simple, unreplicated design to serve as a 
means of nominating candidates for subsequent validation.  Among our candidate 
imprinted genes, we selected 10 for validation with biological replication and an 
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independent assay for allele-specific expression.  One pyrosequencing assay failed, 
but of the remaining nine, eight of the imprinting candidate genes were soundly 
confirmed.   The candidates were chosen from a list with a theoretical false discovery 
rate of 0.01, whereas we observed that 1/9, or 11% of the candidates were false 
discoveries.  The discrepancy between the q-value and the true verification rate could 
arise from several causes, most of which are expected to inflate the false positive rate 
of an unreplicated RNA-seq study. First, for lowly expressed genes, with only a few 
mRNA copies in the transcriptome, there is a chance during library construction that 
only one of the two alleles might be randomly ligated to the adapter and included in 
the final pool. After sequencing, the gene would resemble a monoallelically expressed 
gene, when in fact it is not. This is different from the random monoallelic expression 
that has been reported previously (Lomvardas et al. 2006; Gimelbrant et al. 2007), 
where single cells appear to fail to express both alleles.  In applying quantitative 
RNA-seq for allele-specific expression, it is critical to assure that high library 
complexity is attained in order to avoid this allelic dropout caused by an insufficiently 
complex library.    We might not get conclusive results for lowly expressed genes, so 
we need other independent methods to verify candidates with low expression levels.  
Second, sequencing bias and mis-alignments could also be a source of discordance. 
For the statistical test and subsequent inference of a q-value, several assumptions 
producing ideal experimental conditions are made: there is no sequencing bias, no 
mis-alignments, and the SNP-containing read counts are in proportion to the allelic 
expression ratio. However, in practice, these assumptions are easily violated. As a 
result, SNPs that truly have technical problems will be among the candidates that are 
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found to be statistically significant by the Storer-Kim test, and these will be false 
positive calls. This is another reason why we need independent verification using an 
orthogonal technology like pyrosequencing. To account for these factors, we used 
more stringent filters. With our criterion 3 (defined as RPKM>3 and SNP 
coverage>20), only 113 significant candidates were left. Among the 113 genes, most 
of the known ones (23/35) and the confirmed novel ones (4/5) are preserved.  Thus, 
by applying expression level and SNP coverage cut-offs, the degree of library 
complexity and SNP bias problems will be reduced, resulting in a lower false 
discovery rate. We will reach the theoretical FDR only if we completely remove these 
effects and meet all the ideal experimental conditions, and the most obvious way to 
improve the situation is by replication. But it is important to note that even with only a 
single replicate of RNA-seq runs from each cross, valid, verifiable novel imprinted 
genes were discovered.   
 
Many pairs of known imprinting genes occur as overlapping sense-antisense pairs 
(Morison et al. 2005; Wang et al. 2008). With a double-strand cDNA RNA-seq 
library, the allelic expression from the sense vs. antisense transcripts cannot be 
distinguished, so SNPs that fall in regions where both strands are transcribed may 
produce false negative calls. By closely examining the SNPs within the candidates, we 
found some problematic genes with inconsistent SNPs or overlapping sense-antisense 
gene models. This could also contribute to the low verification rate. In the future, 
methods that allow preparation of strand-specific RNA-seq libraries should solve this 
problem (Levin et al. 2010).  
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Given the various limitations of RNA-seq studies, we conclude that an independent 
verification such as pyrosequencing or other allele-specific methods is necessary to 
confirm the imprinting status. It is also important to examine biological replicates, 
ideally from individuals from different strains to test the possibility of strain-specific 
effects.   A much larger study, with a well-replicated and blocked design of multiple 
RNA-seq runs (Auer and Doerge 2010) would be needed to generate a definitive count 
of the number of imprinted genes. From our data, ~4.5% (251) of the 5,527 genes 
having sufficient data to perform the test exhibit significant imprinting in the placenta. 
Given the empirical FDR of 11% for this test, 224 genes are expected to be verified. 
However, the 11% false positive rate was seen among the subset of genes with the 
lowest q-values, and if all 251 genes were tested, it would likely be higher.   On the 
other hand, the gene list of 251 was generated using strict selection criteria (RPKM 
>1, p1 > 0.65 or p1<0.35), and the un-measured false negative rate be inflated. 
Therefore, while the experiment produces an estimate of 224 imprinted genes, the 
uncertainty in false positive and false negative rates suggest that a range of 100-250 
genes may be the most supportable.   Because this study was restricted to the E17.5 
placental tissue in AKR-PWD crosses, the true number of imprinted genes across all 
tissues and stages is likely to be larger.   
 
Artifacts in novel imprinted gene identification 
There are various sources of artifacts in the identification of imprinted genes 
(Proudhon and Bourc'his 2010). The first one is that there may be random monoallelic 
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expression instead of genomic imprinting. We verified our candidates in multiple 
individuals to exclude this possibility.  Second is that the allelic bias could be 
generated by an eQTL effect. In our study, we used reciprocal F1s, allowing us to 
distinguish parent-of-origin effects from the eQTL effects. Third, there may be a 
strain-specific PCR bias. Random primers were used in the Illumina library 
preparation, making PCR bias unlikely, and our confirmation method using 
pyrosequencing did not employ the same PCR primers. The fourth class of artifact is 
maternal contamination in the dissected placenta tissues. We took pains to avoid and 
to quantify the maternal contamination in our samples, and our quantitative analysis 
demonstrates that these efforts were successful (Table 23).  Another artifact that 
might spuriously lead to allelic bias is homology to the X chromosome. Males inherit 
the X chromosome from the mother, so the X-linked genes in males will have 100% 
maternal expression. In female mouse embryos and placental tissues of fetal origin, 
there is imprinted X inactivation, resulting in preferential expression from the 
maternal allele. If an autosomal gene/SNP has X homology, there could be non-
specific amplification during RT-PCR or mis-alignment for the RNA-seq. Either case 
would result in spurious identification of a maternally expressed imprinted gene. This 
could happen even with zero maternal contamination. Careful attention to this 
possibility during read-mapping should minimize its impact, although it is hard to 
exclude the possibility entirely. 
 
Is there a paternal-brain and maternal-placenta bias?  
Previous literature indicates that there is a maternal bias to allelic expression of 
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imprinted genes in the placenta (Morison et al. 2005; Proudhon and Bourc'his 2010). 
This could be real, or it may be due to over-estimation of maternally expressed 
imprinted genes due to maternal contamination or under-estimation of the paternally 
expressed imprinted genes. From our results, we did not observe any bias toward 
maternally expressed imprinted genes in the placenta (Figure 37). We think this is 
simply because some paternally expressed genes are not known to be imprinted in 
placenta. In the 12 known imprinted genes identified in our data without prior reports 
of placenta imprinting, 8 of them are paternally expressed. In the list of novel 
candidate imprinted genes, we did not find any bias toward maternally expressed 
genes. This is also consistent with the minimal maternal contamination estimated in 
our study.  
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Conclusion   
 
We have shown that even an unreplicated RNA-seq study can identify a highly 
informative set of genes showing parent-of-origin allelic expression differences that 
validated with a quite acceptable rate (89%).  This provides an excellent set of 
candidates for genes showing genomic imprinting, including 5 novel genes that we 
validated by pyrosequencing in multiple biological samples.  The finding that Phf17 
shows strong paternally expressed imprinting is especially intriguing, as this gene is 
part of a histone H4 transacetylase complex, and may specify a parent-of-origin 
differential histone acetylation.  It is not immediately clear why Pde10a, a cAMP and 
cGMP phosphodiseterase should be maternally expressed and imprinted in the 
placenta, but the allelic expression bias is well validated. A larger scale RNA-seq 
study with this reciprocal cross design, sequencing to greater coverage and using 
biological replication would also be highly informative, allowing assessment of splice 
isoform-specific imprinting, sex difference in imprinting, inter-strain variability, and 
more.  
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CHAPTER 4  
Biased paternal X inactivation in mouse brain3 
Abstract 
 
X-inactivation in female eutherian mammals has long been considered to occur at 
random in embryonic and postnatal tissues. Methods for scoring allele-specific 
differential expression with a high degree of accuracy have recently motivated a 
quantitative reassessment of the randomness of X inactivation. After RNA-seq data 
revealed what appeared to be a chromosome-wide bias toward under-expression of 
paternal alleles in mouse tissue, we applied pyrosequencing to mouse brain cDNA 
samples from reciprocal cross F1 progeny of divergent strains and found a small but 
consistent and highly statistically significant excess tendency to under-express the 
paternal X chromosome. The bias toward paternal X inactivation is reminiscent of 
marsupials (and extraembryonic tissues in eutherians), suggesting that there may be 
retained an evolutionarily conserved epigenetic mark driving the bias.  Allelic bias in 
expression is also influenced by the sampling effect of X inactivation and by cis-acting 
regulatory variation (eQTL), and for each gene we quantify the contributions of these 
effects in two different mouse strain combinations while controlling for variability in 
Xce alleles.  In addition, we propose an efficient method to identify and confirm 
genes that escape X inactivation in normal mice by directly comparing the allele-
specific expression ratio profile of multiple X-linked genes in multiple individuals.
                                                 
3 This work was published in Wang X, Soloway PD, Clark AG., 2010. Paternally biased X inactivation 
in mouse neonatal brain. Genome Biol., 11(7):R79. 
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Introduction 
In placental mammals, dosage compensation is achieved during embryonic 
development by random inactivation of one of the two female X chromosomes (Straub 
and Becker 2007; Payer and Lee 2008).  In male germline tissue, both sex 
chromosomes are inactivated through meiotic sex chromosome inactivation (MSCI).  
In the mouse placenta, the paternal X chromosome (Xp) is inactivated in extra-
embryonic tissues.  In female zygotes, at the two-cell stage, Xp is activated and X-
linked genes are transcribed from both parental X chromosomes. In the mouse, 
starting from the eight-cell stage, the paternal X is inactivated through a process 
known as imprinted X inactivation (Huynh and Lee 2001; Huynh and Lee 2005; Heard 
and Disteche 2006). Subsequently the paternal X is reactivated and, in the mouse, 
random X inactivation occurs around the implantation stage (about day 6.5) in the 
embryonic tissue, with only one of the two X chromosomes remaining activated 
(Cheng and Disteche 2004), while the extraembryonic tissues retain imprinted X 
inactivation and express only the maternal X. This would seem to be a cumbersome 
way to accomplish dosage compensation, and an evolutionary perspective may shed 
light on the origins of the process. In humans, there remains some controversy 
surrounding the presence of imprinted X inactivation. There is some evidence of 
imprinted inactivation in pre-implantation embryos, but it has not been fully 
confirmed (Goto et al. 1997; van den Berg et al. 2009). Most placental mammals 
appear to perform dosage compensation in the same fashion as the mouse, whereas in 
marsupials X inactivation is not complete but instead preferentially silences the 
paternal allele in both embryonic and extraembryonic tissues (Cooper et al. 1990). In 
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the egg-laying monotremes (platypus and echidna), both alleles of X-linked genes are 
transcribed, and some of the genes do not display dosage compensation while others 
show some degree of compensation by gene-specific transcriptional inhibition (Deakin 
et al. 2008). This is consistent with the fact that the platypus X chromosomes are not 
homologous to the human X, but instead have molecular sequence similarity to the 
chicken Z chromosome (Warren et al. 2008), and birds do not appear to effect dosage 
compensation by Z inactivation (Arnold et al. 2008).    
 
In eutherian mammals, imprinted X inactivation is reported in extraembryonic tissues, 
and in embryonic tissue early in development prior to random X inactivation. Skewed 
X inactivation can affect the severity of human disorders such as PHACES (posterior 
fossa malformations, hemangiomas, arterial anomalies) (Levin and Kaler 2007), Rett 
Syndrome (Krepischi et al. 1998) and other diseases (Martinez et al. 2005; 
Talebizadeh et al. 2005; Shimizu et al. 2006). However, aside from extraembryonic 
tissues, it is widely thought that placental mammals inactivate one or the other X 
chromosome in a purely random fashion (except the loci that clearly influence choice 
such as the Xce alleles, and Xist polymorphisms). Two earlier studies found possible 
parental influence on the biased expression of the maternal allele, but their data are 
only from a single X-linked gene, and so it is not possible to distinguish between 
explanations involving single gene effects (such as imprinting) or those that would 
generate chromosome-wide patterns (such as X-inactivation)  (Forrester and Ansell 
1985; Fowlis et al. 1991). In this report, we quantify the relative paternal and maternal 
expression level of 33 X-linked genes from P2 neonatal brains of 18 female mice for 
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each of the two reciprocal F1 progeny of AKR and PWD strains. These data reveal a 
significant and consistent elevated expression level from the maternal X, consistent 
with preferential paternal X inactivation in normal non-extraembryonic tissue. The 
same pattern of preferential paternal X inactivation was also seen in our examination 
of reciprocal F1 progeny of the B6 and CAST strains.  
 
Not all X-linked genes are subject to X inactivation. In humans, Carrel and Willard 
(2005) reported that roughly 15% of the X-linked genes are expressed from both 
alleles. To date, in the mouse, four genes that escape X inactivation have been 
discovered outside the pseudo-autosomal region (PAR) (Adler et al. 1991; Agulnik et 
al. 1994; Disteche et al. 2002).  Human studies have nearly completed a scan for 
genes that escape X inactivation by thorough testing of murine-human hybrid cell 
lines, as well as human fibroblast samples (Brown and Willard 1989; Brown et al. 
1997; Carrel et al. 1999; Carrel and Willard 2005). Early mouse studies employed 
female mice carrying the T(X;16)16H (T16H) translocation (Agulnik et al. 1994; 
Greenfield et al. 1998), and recently Yang et al. (Yang et al. 2010) showed from 
RNA-seq of mouse hybrid cell lines that biallelic expression is found for 13 of the 393 
X-linked genes examined. Here, we employ a novel method to detect X inactivation 
status using normal somatic tissue (P2 neonatal brains) from reciprocal mouse crosses, 
by comparing the allele-specific expression profiles among many X-linked genes and 
autosomal genes in multiple individuals. We confirm the status of two known mouse 
genes that escape X inactivation, and see a consistent pattern wherein one gene 
partially escapes X inactivation. We also test 13 orthologs of known genes that escape 
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X inactivation in humans and find that all are subject to X inactivation in mouse. The 
method presented here is a valuable complement to the current methods, and by 
applying it to all mouse and human X-linked genes, it will be possible to build an 
exhaustive catalog of mouse and human X inactivation escapers.  
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Materials and Methods 
Mouse Strains and crosses 
Four mouse strains (AKR/J, PWD/PhJ, C57BL/6 and CAST/EiJ) were purchased 
from the Jackson Laboratory (Brondum-Nielsen and Pedersen 2001). We performed 
reciprocal crosses with two strain combinations (PWD/PhJ x AKR/J, AKR/J x 
PWD/PhJ, C57BL/6 x CAST/EiJ, CAST/EiJ x C57BL/6). 18 female P2 F1 mice were 
generated from 5 litters from the PWD/PhJ x AKR/J cross (PWD x AKR for short). 18 
female P2 F1 mice were generated from 4 litters from the AKR/J x PWD/PhJ cross 
(AKR x PWD for short). 11 female P2 F1 mice were generated from 3 litters from the 
C57BL/6 x CAST/EiJ cross (B6 x CAST for short). 11 female P2 F1 mice were 
generated from 4 litters from the CAST/EiJ x C57BL/6 cross (CAST x B6 for short). 
Total RNA samples were extracted from the P2 F1 mouse whole brains using the 
Qiagen RNeasy Lipid Tissue Mini Kit. RNA concentrations and A260nm/A280nm 
ratios were checked with a NanoDrop ND-1000 spectrophotometer. RNA integrity 
was checked using the Agilent 2100 Bioanalyzer. All of the samples have a RIN 
(RNA integrity number) in the range 9.8-10.0 (RINmax = 10.0).   
 
All procedures involving mice have been approved by the Institutional Animal Care 
and Use Committee at Cornell University (protocol number 2002-0075).  Cornell 
University is accredited by AAALAC. 
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Illumina sequencing of the transcriptome and allele-specific expression analysis 
Experimental procedures, statistical methods, and data from our original RNA-seq 
study are available (Wang et al. 2008) (see Chapter 2).  
 
Quantification of allele-specific expression of 35 genes by pyrosequencing  
33 X-linked genes (Ctps2, Plxna3, Syn1, Phf6, Taf1, Utx, Syap1, Maoa, Zfx, 
Xist, Usp9x, Ddx3x, Ikbkg, Prkx, Eif2s3x, Nxt2, Gpm6b, Nudt11, Zbtb33, Sh3bgrl, 
Fundc1, Wdr13,Hcfc1, Rbmx, Uba1, L1cam, Ofd1, Crsp2, Cstf2, Ids, Jarid1c, Tsix 
and Xite) and 8 autosomal genes (Pex7, NM_023057, Prkar2b, Hibadh, Rgs17, 
Cab39l, Trpm6 and Tmem109) were selected for quantification of expression level 
from the two parental alleles using pyrosequencing in 18 female brain samples from 
each of AKR-PWD reciprocal crosses. 18 X-linked genes and the same 2 autosomal 
genes were examined in 11 female brain samples from each of B6-CAST reciprocal 
crosses. The X-linked gene selection criteria include genes having a detectable 
expression level in the Illumina sequence data, including known mouse genes that 
escape X inactivation (Disteche et al. 2002) and orthologs to human genes that escape 
X inactivation and are subject to X inactivation, respectively (Carrel and Willard 
2005). Genes were selected to span the entire mouse X chromosome with a relatively 
even distribution. The eight autosomal genes were selected at random among the 
genes that have a detectable expression level in the Illumina sequence data. In 
addition, one male sibling of the tested females was included from each litter and was 
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used as a pyrosequencing control, since males should have 100% maternal allele 
expression, if there is no Y homolog of that gene.  
 
Pyrosequencing PCR and sequencing primers were designed for the selected X-linked 
and autosomal control genes with the pyrosequencing Assay Design Software Version 
1.0.6 (Biotage AB). To guarantee that there were no SNPs within the primers, SNP 
positions in the Perlegen SNP database (Frazer et al. 2007) were labeled and excluded 
when designing the primers. The detailed PCR amplification and allele-specific 
pyrosequencing protocol can be found in (Wang et al. 2008). Pyrosequencing was 
done twice for each gene in each sample, and the mean difference is 1.90%, with 
standard deviation 1.52%, indicating high reproducibility.  
 
Statistical analysis  
Cluster analysis of the X-linked genes. 33 X-linked genes and 2 autosomal genes 
were clustered using the Agglomerative Nesting Hierarchical Clustering method 
(Blashfield 1991), which is implemented in the cluster package (version 1.11.11) 
(Buettner et al. 2004) in R (version 2.62) (Bullard et al. 2010). Absolute Pearson 
Correlation distance was used as the dissimilarity measure.  
Nested ANOVA methods.  To determine whether there is significant maternal bias 
and/or sampling effect, a three-factor nested ANOVA model was implemented.  
( )i jijk k jy           
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In this model, yijk is the response variable of observed PWD maternal/paternal 
expression ratio for the ith gene (cis-regulatory effect), kth individual (sampling effect) 
in jth cross (parent-of-origin effect).  is the mean PWD expression ratio. i is the 
fixed effect for individual genes (i = 1,…,27). j is the parent-of-origin effect (j = 1, 2 
for the PWD x AKR and AKR x PWD crosses). k(j) is the sampling effect nested 
within the parent-of-origin effect (k = 1,…, 18). The data were analyzed in SAS using 
the Proc Mixed procedure, with gene and mother as fixed factors, and individual as 
random factor nested in mother.  
   
Estimation of number of brain-forming cells during X inactivation.  For each of the 
PWD-AKR reciprocal crosses, we simulated the mean sampling variance 1,000 times 
for the number of brain-forming stem cells N ranging from 30 to 150, using the 
rbinom() function in R (version 2.62) (Bullard et al. 2010).  The mean and 95% CI 
were estimated by interpolation. 
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Results 
 
Maternal bias in transcriptome-wide differential allelic expression  
In our previous effort to identify novel imprinted genes in mouse (Wang et al. 2008), 
we performed an “RNA-seq” study in which >69 million sequence reads were 
sampled from the transcriptomes of reciprocal F1 female P2 neonatal brains (AKR/J 
and PWD/PhJ strains) by Illumina short-read sequencing.  Relative expression ratios 
of the two parental alleles were obtained by directly counting the allele-specific 
sequence reads at the SNP positions within the transcripts (Wang et al. 2008). 5,076 
unique Entrez genes had a coverage of four or more sequence reads overlapping each 
SNP position in both reciprocal crosses across the mouse genome. The imprinting 
status was quantified as the difference between the AKR percentages in the F1 
progeny derived from the two reciprocal crosses.  For most genes this difference in 
expression was close to zero, indicating a lack of significant imprinting (Wang et al. 
2008) . The known imprinted genes and novel imprinted gene candidates had an 
obvious and highly statistically significant bias in allelic expression. When we 
compared the pattern of skewed allelic expression of autosomes with the X 
chromosome, we noted that for every autosome, there was approximately the same 
number of preferentially paternally and maternally expressed genes. However, X 
chromosomal genes showed consistently elevated maternal expression, and there was 
not a single significant paternally over-expressed gene (Figure 38). Because we saw 
exclusively maternal over-expression in progeny of both reciprocal crosses of PWD 
and AKR strains,  the results cannot be explained by differences in alleles at the X 
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chromosome control element (Xce), a locus that influences in an allele-specific 
manner the probability of X inactivation (Cattanach and Isaacson 1967). 
 
There are three possible explanations for the maternal bias in X-linked expression. 
First, the pattern might be driven by each X-linked gene having its own independent 
factors driving its imprinting. Second, since the RNA-seq data are from only two 
mice, we cannot exclude the possibility of a sampling effect caused by the small 
number of cells at the time of X inactivation. X inactivation initiates when the total 
number of cells committed to become brain is only 10 to 50 (Gartler and Riggs 1983). 
If X inactivation occurs as an independent Bernoulli trial for each cell, then the count 
of cells expressing maternal vs. paternal alleles would have a binomial variance.  
Such sampling effects will yield an X inactivation process that may still be truly 
random for all single cells, but in aggregate there may appear to be a bias due to the 
small cell sample size at the time of X inactivation. This phenomenon was seen in 
humans by an allele-specific methylation assay of the AR (androgen receptor) gene (X 
chromosome inactivation assay) (Amos-Landgraf et al. 2006). The third possibility is 
that there may be preferential inactivation of the paternal X chromosome, in violation 
of the standard notion of random X-inactivation, and that this bias may act on top of 
the sampling effect. In this study we applied pyrosequencing to multiple F1 progeny 
samples to determine whether the skewed allelic expression we saw in our mouse 
imprinting study was due to such a sampling effect.  
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Figure 38. Chromosomal scans of imprinting status for chromosome 11 and X.  
Each plot contains unique Entrez genes covered by SNP-containing Illumina 
reads with counts no less than 4 in each reciprocal cross.  The height of each 
bar is the difference of the AKR percentage in the two reciprocal crosses (p1-
p2), representing the intensity of imprinting. The color indicates for the 
direction of expression bias, blue for paternal over-expression and red for 
maternal over-expression. The intensity of the color represents the 
significance, grey for not significant (q-value ≥ 0.10), lighter blue and pink for 
marginally significant (0.05 ≤ q-value < 0.10), darker blue and red for 
significant (q-value < 0.05). The gene name is indicated for the instances 
where | p1-p2| ≥ 0.3. Data are from Chapter 2. 
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The maternal bias is unlikely to be due to individual imprinted genes 
To determine whether the maternal bias is due to several X-linked imprinted genes or 
a chromosome-wide effect, we plotted the distribution of the difference in expression 
between reciprocal F1 progeny for the X chromosome from our RNA-seq data (Figure 
39). The distributions of all autosomes are centered near zero (mean is 0.000975), 
whereas the distribution for the X chromosome is shifted to a mean of -0.176. Pairwise 
Kolmogorov-Smirnov tests revealed a significant difference between the X 
chromosome and autosomal allelic bias (P < 10-12 for all chromosomes), but no 
significant heterogeneity among autosomes, indicating that the bias in X-linked allelic 
expression is a chromosome-wide effect (Table 27). Further verification in multiple 
individual mice confirmed that none of the 26 tested X-linked candidate imprinted 
genes are consistent with classical genomic imprinting. We observed variable allele-
specific expression ratios in multiple individuals of the two reciprocal crosses. If the 
maternal bias that we observed were caused by independent imprinting of each gene, 
and if there is no prior reason to assume a bias toward maternal or paternal imprinting, 
then the chance that all 26 genes are maternally-expressed imprinted genes would be 
(1/2)26, a vanishingly small number. We conclude that biased X inactivation is a much 
more parsimonious explanation than maternally-biased imprinting for the observed 
maternal bias in allelic expression of so many X-linked genes.  
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Table 27. Kolmogorov-Smirnov tests of p1-p2 distribution of different chromosome 
pairs. 
 
 155 
 
 
 
 
 
 
 
 
 
Figure 39. Distribution of imprinting status of 5000 genes covered by the RNA-seq 
study in mouse brain. Boxplot of the imprinting status for autosomes and the X 
chromosome. The y-axis is proportion bias from the paternal allele (p1-p2). From the 
plot, for all autosomes, the mean is very close to zero. However, the mean for X 
chromosome is -0.17, which indicate a 17% maternal bias in allele-specific 
expression. The difference between X and autosome is extremely significant from 
non-parametric statistical test of distributions. So this is a chromosome-wide effect, 
rather than effect of single imprinted genes. 
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Sources of variability in allele-specific expression 
To further elucidate the cause of maternal bias in expression of X-linked genes in 
(Figure 38), we employed pyrosequencing to quantify the parental expression ratios of 
33 X-linked genes and 8 autosomal genes in 18 female P2 brains in each of the PWD 
and AKR reciprocal crosses (Marsh 2007). First, we selected genes that had a 
detectable level of expression in our Illumina RNA-seq data. We included the known 
mouse genes that escape X inactivation as well as mouse orthologs to human genes 
that escape X inactivation, genes with variable X inactivation status, and genes that are 
subject to normal X inactivation (Carrel and Willard 2005). We also randomly 
selected eight autosomal genes as controls (Table 28).  
 
There are three possible sources of variability for the allele-specific expression ratio 
we quantified by pyrosequencing: a sampling effect, a cis-regulatory effect (also 
called an eQTL effect) and a parent-of-origin effect. We already explained the 
sampling and parent-of-origin effects as possible causes of the maternal expression 
bias. An eQTL effect occurs when there is a cis-regulatory polymorphism near the 
gene. In this case, if the PWD allele of the regulatory variant confers elevated 
expression, then for all progeny and in both reciprocal crosses, the effect of the PWD 
cis-acting effect will be to increase the PWD allele expression relative to the AKR 
allele.  The eQTL effect may be different for each gene. Since the eQTL effect drives 
a bias in expression among progeny of both reciprocal crosses, it cannot cause the 
observed maternal bias.  
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We illustrate the possible patterns of differential allelic expression under the three 
different effects in (Figure 40). For autosomal genes and X-linked genes that are 
subject to X inactivation, because there is no sampling effect (no X inactivation), there 
will not be much variability (Figure 40A). The only source of allele-specific 
variability is the measurement error of the pyrosequencing assay. For the X-linked 
genes that are subject to X inactivation, because there are only a few brain-forming 
cells at the time of X inactivation, there is a sampling effect over the counts of cells 
expressing one X or the other, and the among-individual variance will be large (Figure 
40B). The standard model for X-inactivation posits that the offspring from the two 
reciprocal crosses should have essentially the same mean and variance in their allele-
specific expression ratios. Among a set of X-linked genes that display both a sampling 
effect and an eQTL effect, there will be differences in mean expression percentages 
from the PWD allele, but the means for the two reciprocal crosses are still expected to 
be the same (Figure 40C). Only if there is a parent-of-origin effect will the means of 
the PWD expression percentages be different between the two reciprocal crosses, and 
the bias will be in the same direction for every single gene that is subjected to X 
inactivation (Figure 40D).  
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Table 28. Gene selection for Pyrosequencing. 
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Figure 40. Three effects that cause the allele-specific expression variability. In 
these plots, the y-axis quantifies the proportion of expression from the PWD 
allele (PWD percentage). The x-axis provides an arbitrary index for different 
individuals from the reciprocal crosses. The left panels show offspring from the 
PWD x AKR cross, and the left panels show offspring from the AKR x PWD 
cross. Different colors represent different X-linked genes.  
(A) A diagram to illustrate the allele-specific expression results when there is 
no sampling effect, no eQTL effect and no parent-of-origin effect. In this case, 
there is little variability of PWD allelic expression among individuals or among 
the two reciprocal crosses. The only source of variability is the pyrosequencing 
measurement error. This is the case for the autosomal genes and X-linked 
genes that escape X inactivation.  
(B) A diagram to illustrate the sampling effect caused by random X 
inactivation. In this diagram, the X inactivation process itself is random, but the 
number of brain-forming cells is small during the time of X inactivation, 
resulting in sampling variation among individuals. Although individuals are 
expected to show a 1:1 expression ratio, if each cell randomly and 
independently inactivates one or the other X chromosome, then we expect to 
see a binomial distribution of counts of cells inactivating the maternal vs. 
paternal X.  If the count of cells is small, the variance in expression ratios 
could be large, and a maternal bias observed in a small number of individuals 
might be explained by this sampling effect.  The sampling effect of X 
inactivation also drives the observed co-variation of allelic bias in expression 
of all X-linked genes. 
(C) A diagram to illustrate the eQTL effect. If there is a cis-regulatory 
polymorphism near the respective gene, it may drive differential allelic 
expression yielding allelic expression counts different from 1:1. The regulatory 
variant might drive higher expression from the PWD or the AKR allele, so the 
mean PWD expression percentage is not 50%. Such an effect would be allele-
specific (or strain-specific), and would not explain differences in expression 
between reciprocal crosses or a maternal bias.  
(D) A diagram of preferential paternal X inactivation. Here the X inactivation is 
NOT random and the paternal X is preferentially inactivated. In this case we 
will observe greater expression from the maternal allele.  The bias is like that 
of a biased coin.  For small numbers of tosses, not all samples will show a 
skewed ratio of heads to tails, but with a sufficiently large sample, the bias will 
appear as a shift in the mean. In this cartoon, a comparison of the two 
reciprocal crosses shows that the allele-specific expression profile is shifted.  
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Combined effect of sampling and preferential paternal X inactivation  
In our pyrosequencing experiment, the three sources of variation, namely sampling 
effects, eQTL effects, and parent-of-origin effects are superimposed, and all may 
contribute to the variability in allele-specific expression percentages. We will now 
show how statistical tests allow quantitative partitioning of these effects from the 
PWD percentages of these X-linked genes across the 36 individual female progeny:  
 
(i). Sampling effect. We studied 26 genes that are subjected to X inactivation, shown 
in Figure 41. In Figure 41A, the X-linked genes vary in parallel with each other, 
indicating that from one mouse to another, the allele-specific expression ratio of these 
genes covary in a concerted fashion.   If by chance in one mouse 70% of inactivated 
X chromosomes were paternal and 30% were maternal, this sampling effect would 
produce a consistent pattern of excess maternal expression in all the X-linked genes 
examined (or at least those that undergo normal X-inactivation).  Among different 
individual mice, we expect to see such sampling variation due to the small number of 
brain-forming stem cells at the time of X inactivation early in development.   
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Figure 41. Allele-specific expression ratio of 37 genes in P2 brains of 18 
female F1 progeny from each of the two reciprocal crosses between AKR and 
PWD strains.  
(A). Allele-specific expression profiling of 26 genes that are subject to X 
inactivation. The pink boxplot in the middle is the distribution of PWD 
expression percentage from the PWD x AKR cross for all X-linked genes that 
are subject to X inactivation. It is labeled pink because PWD is the maternal 
allele in this cross. The blue boxplot is the distribution of PWD expression 
percentage from the AKR x PWD cross. It is labeled blue because PWD is the 
paternal allele in this cross. 
(B). Allele-specific expression profiling of known genes that escape X 
inactivation in mouse: Utx and Eif2s3x.  
(C). Allele-specific expression profiling of known genes that escape X 
inactivation in mouse: Ddx3x and Jarid1c. 
(D). Allele-specific expression profiling of four autosomal genes: Cab39l , 
Pex7, Hibadh and Trpm6.  
(E). Allele-specific expression profiling of Xist, Tsix and Xite transcripts.  
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(ii). cis-regulatory effect.  Within each individual, not all the genes have the same 
level of allele-specific expression from the PWD allele. This is because the two alleles 
differ in cis-regulatory activity, and the cis-regulatory differences are specific to each 
gene. If there is a strain-specific cis-regulatory SNP near the gene, it will produce an 
elevated relative expression from the allele coming from one strain, in the offspring of 
both reciprocal crosses  
 
(iii). Preferential paternal X inactivation.  In addition to the sampling and eQTL 
effects, we also observed a parent-of-origin effect of random X inactivation. The 
average PWD expression percentage for 26 genes that are subject to X inactivation in 
the PWD x AKR cross is 50.4%, whereas the average in the AKR x PWD cross is 
44.0% (Figure 41A). This difference, while quantitatively modest, is highly 
statistically significant.  
 
Statistical analysis of the three factors affecting X expression ratios 
In order to quantify the three effects discussed above and to assess their statistical 
significance, a nested analysis of variance (ANOVA) model was implemented. We 
assume that each individual represents an independent sampling trial at the time of X 
inactivation. There are two fixed factors, “cis-regulatory” and “parent-of-origin”, as 
well a random factor “sampling” nested within “parent-of-origin”. The “cis-
regulatory” factor refers to the consistent allelic bias as one might see if there were 
cis-acting (eQTL) factors that result in, for example, an over- or under-expression of 
the AKR allele relative to the PWD allele. Our data cover 27 genes that are subject to 
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X inactivation (26 genes in Figure 41A and Ddx3x), and because each gene may have 
a different magnitude of such cis-acting expression effects, the cis-regulatory factor 
has 27 levels. The “parent-of-origin” factor represents the differences seen in allelic 
bias between reciprocal crosses (PWD x AKR and AKR x PWD). The “sampling” 
factor is nested in the “parent-of-origin” factor, with 18 independent trials from each 
of the two reciprocal crosses. From the nested ANOVA results (Table 29), there is a 
significant “cis-regulatory” effect (P < 0.001), indicating that there is highly 
significant heterogeneity in allelic expression across these X-linked genes (Table 29 
and Table 30; Figure 41A andFigure 42A). Some genes have higher average 
expression from the PWD allele, and some genes have higher average expression from 
the AKR allele (Figure 43). The “parent-of-origin” effect is also highly significant (P 
= 0.0045), suggesting preferential paternal X inactivation (Table 29; Figure 43). We 
saw the same trend of preferential inactivation of the paternal allele in the B6 and 
CAST strain combination (Figure 42A). The “sampling” effect nested in the parent-of-
origin factor is significant as well (P < 0.0001), showing a substantial amount of 
variation of the sampling effect (Table 29; Figure 41A andFigure 42A). We also 
applied a non-parametric test by rank transformation (Conover and Iman 1981), all 
three effects remain highly significant, with P < 0.0001, P = 0.0051 and P < 0.0001 
for the cis-regulatory, parent-of-origin and sampling effect respectively (Table 31). 
The effect size was estimated by variance component analysis.  The sampling effect 
explains 30.9% of the total variance. The parent-of-origin effect explains 14.3% of the 
total variance, and the cis-regulatory effect explains 48.3% of the total variance (Table 
32). We applied the method of Least-Squares Means to obtain an LS-mean for PWD 
 166 
mothers (in the PWD x AKR cross) of 0.4985 (SE = 0.01464, Table 30), and the LS-
mean for AKR mothers (AKR x PWD cross) 0.4355 (SE = 0.01464). In B6-CAST 
reciprocal crosses, the estimate for CAST mothers (CAST x B6 cross) is 0.6706 (SE = 
0.02403), and the estimate for B6 mothers (B6 x CAST cross) is 0.6160 (SE = 0. 
02403). Since we found a similar degree of maternal bias (about 6%) in B6-CAST 
progeny as in PWD-AKR progeny, we analyzed the two datasets together. The P-
value of the “parent-of-origin” effect for the pooled data is even smaller (P < 0.0020) 
(Table 33). We conclude that the maternal bias or the degree of preferential paternal X 
inactivation is about 6%.  
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Table 29. Analysis of variance table of the PWD-AKR data of X-linked genes 
subject to X inactivation. Type III sums of squares are reported. 
Source Sum of Squares Mean Square DF F Value Pr > F
Gene 10.96479 0.421723 26 524.83 <.0001
Mother 1.822754 1.822754 1 9.25 0.005
individual(mother) 6.700906 0.197085 34 245.27 <.0001
Residual 1.428698 0.000804 1778  
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Table 30. Least-squares means (LS-means) of fixed effects gene and mother. 
 
 
  
 169 
 
 
 
 
 
 
Table 31. Nonparametric analysis of variance table of the PWD-AKR data of 
X-linked genes subject to X inactivation. 
Source Error Term  DF   F Value   Pr > F
gene MS(Residual) 1778 300.87 <.0001
mother 0.9996 MS(individual(mother)) + 0.0004 MS(Residual)  34 8.96 0.0051
individual(mother) MS(Residual)  1778 178.04 <.0001
Residual  
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Table 32. Variance component analysis. 
Variance component 
estimate
% variance 
explained
Variance component 
estimate
% variance 
explained
gene 0.0059768 48.30% 0.0062052 49.24%
mother 0.00177 14.30% 0.001751 13.89%
individual(mother) 0.0038256 30.91% 0.0038431 30.49%
Error 0.000803 6.49% 0.0008035 6.38%
Variance component 
estimate
% variance 
explained
Variance component 
estimate
% variance 
explained
gene 0.0059138 51.51% 0.0063354 50.24%
mother 0.0009369 8.16% 0.0017555 13.92%
individual(mother) 0.0038256 33.32% 0.00387 30.69%
Error 0.0008035 7.00% 0.0006497 5.15%
REML Type 1
ML MIVQUE(0)
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Table 33. Analysis of variance table of the pooled data (PWD-AKR and B6-
CAST crosses) of X-linked genes subject to X inactivation. Type III sums of 
squares are reported. 
 Source    Sum of Squares Mean Square    DF    F Value    Pr > F  
 Gene   13.204705 0.356884  37    466.51    <.0001  
 Mother   2.153376 1.076688  2    6.98    0.0020  
 individual(mother)   9.265601 0.171585  54    224.29    <.0001  
 Residual   1.675383 0.000765  2190        
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Figure 42. Allele-specific expression ratio of 20 genes in P2 brains of 11 
female mice from each of the two reciprocal crosses between B6 and CAST 
strains. 
(A). Allele-specific expression profiling of 11 genes that are subject to X 
inactivation. 
(B). Allele-specific expression profiling of known mouse genes that escape X 
inactivation: Utx and Eif2s3x. 
(C). Allele-specific expression profiling of known mouse genes that escape X 
inactivation: Ddx3x and Jarid1c. 
(D). Allele-specific expression profiling of Xist, Tsix and Xite transcripts. 
(E). Allele-specific expression profiling of two autosomal genes: NM_023057 
and Pex7. 
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 174 
 
Figure 43. Distribution of the PWD allele expression percentage in F1 progeny 
of AKR and PWD reciprocal crosses. The mouse X chromosome map is 
diagrammed in the middle of the figure. Each panel is a boxplot of an X-linked 
gene with its chromosomal position labeled. The red box is the distribution of 
the PWD allele expression percentage in P2 brains of 18 F1mice from the 
PWD x AKR cross (mother listed first). The blue box is the distribution of the 
PWD allele expression percentage in P2 brains of 18 F1mice from the AKR x 
PWD cross. The gene name is listed at the top of the figure. The color of the 
left and right strip label depicts the known X-inactivation status in mouse and 
human, respectively (Orange: genes that escape X inactivation; Purple: genes 
that partially escape X inactivation; Blue: genes subject to X inactivation; 
Black: NA). Note that every gene that undergoes X inactivation shows a 
consistent bias toward excess inactivation of the paternal X (a sign test shows 
the bias to by highly significant, P < 1.5 x 10-8).   
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Identification of genes that escape X inactivation in normal mouse brains 
One way to distinguish the genes that escape X inactivation from those that do not is 
to perform a cluster analysis based on the correlation in allelic bias across genes. We 
found a large and closely related cluster containing most of the X-linked genes (Figure 
44), leaving the two known escapers (Eif2s3x and Utx) and the eight autosomal control 
genes (NM_023057, Pex7, Prkar2b, Hibadh, Rgs17, Cab39l, Trpm6 and Tmem109) 
outside the cluster. The genes within the cluster are the genes that are subject to X 
inactivation, because they are expected to vary in relative allelic expression in parallel 
with each other, as a consequence of the sampling variation in the brain-progenitor 
cells at the time of X inactivation during early development. The genes that escape X 
inactivation do not have this property of correlated allelic bias, and as expected they 
are clearly separated from the cluster. Similarly the autosomal control genes fall 
outside the cluster of genes that are X inactivated.  
 
Unlike the X-linked genes that are subject to X inactivation, eight randomly chosen 
autosomal genes, NM_023057 (on chromosome 2), Pex7 (on chromosome 10), 
Prkar2b (on chromosome 12), Hibadh (on chromosome 6), Rgs17 (on chromosome 
10), Cab39l (on chromosome 14), Trpm6 (on chromosome 19) and Tmem109 (on 
chromosome 19), have much less among-individual variation in PWD expression 
percentage and did not show high correlation with the genes that are subject to X 
inactivation. This is exactly as expected: because the autosomal genes are biallelically 
expressed in the same way in all cells of all individuals, they should exhibit far less 
among-individual variation. To illustrate the profile for autosomal genes with an  
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Figure 44. Cluster analysis of the allele-specific expression ratios of X-linked 
genes in F1 progeny from AKR and PWD reciprocal crosses. Based only on 
the differential allelic expression, genes are clustered using a standard nested 
agglomerative hierarchical clustering (see text for details). The large cluster of 
genes to the left are all subject to normal X inactivation, while the genes that 
escape X inactivation fall on the deeper branches to the right. 
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eQTL effect, four of the eight autosomal genes tested are shown in Figure 41E. For all 
genes we observe no maternal bias (the mean is not significantly different between the 
PWD x AKR and AKR x PWD crosses). For Cab39l and Pex7, there is very little 
eQTL effect, so the PWD:AKR expression ratio is nearly 50%:50%. For Trpm6, there 
is a PWD dominant eQTL effect, and the PWD:AKR expression ratio is about 
60%:40%. For Hibadh, there is an AWD dominant eQTL effect and the PWD:AKR 
expression ratio is about 40%:60%. Unlike the genes that are subject to X inactivation, 
the PWD:AKR expression ratios of the autosomal genes do not flip in the reciprocal 
crosses (Figure 41E). NM_023057 and Pex7 were also tested in the B6-CAST 
reciprocal crosses (Figure 42E).  
 
For genes that escape X inactivation, since there is no sampling effect, we expect less 
among-individual variation in PWD expression ratios, just like the autosomal genes. 
Among the four known genes that escape X inactivation in mouse, allelic expression 
of Eif2s3x and Utx was much less variable among individual mice, and was not well 
correlated with the genes that do undergo X inactivation (Figure 41B and Figure 42B). 
This is consistent with their escaper status (Figure 43 and Figure 44). The other two 
previously reported genes in mouse, Ddx3x and Jarid1c (also known as Smcx), 
clustered with the genes that are subject to X inactivation. Jarid1c expression showed 
a weak correlation (Figure 41C and Figure 42C). This is consistent with the fact that 
Jarid1c only partially escapes X inactivation with approximately 30% expression from 
the inactivated X chromosome (Carrel et al. 1996; Li and Carrel 2008). The Ddx3x 
gene showed a perfect correlation with all the other X-inactivated genes, implying that 
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Ddx3x in fact displays normal X inactivation in neonatal mouse brain. The 
discrepancy could be due to tissue-specificity of X inactivation, or spurious expression 
effects resulting from the aberrant genomic configuration of the translocation mouse 
line used in other studies.  
 
We also tested three genes in the Xic (X inactivation center), namely Xist, Tsix and 
Xite. We observed that Tsix and Xite are correlated with one another (Figure 41D and 
Figure 42D), which is consistent with the notion that Xite is regulating Tsix in cis. 
Note that the correlation is not perfect, because the low expression level of Tsix 
resulted in a weak pyrosequencing signal, and the expression level of Xite is even 
lower. However, we did detect expression of these two genes in the RNA-seq and 
pyrosequencing data based on the GenBank gene models. For Xist, we observed a 
large eQTL effect, with about 90% expression from the AKR allele in both AKR x 
PWD reciprocal crosses (Figure 41D and Figure 44), and about 80% expression from 
the B6 allele in both B6 x CAST reciprocal crosses (Figure 42D). The reason for this 
is the strength of the Xce (X controlling element) locus is different among mouse 
strains. Xce is mapped to a region near the Xic which contains the Xite gene, the 
promoter of Tsix, as well as the pairing region of the two X chromosomes (Simmler et 
al. 1993; Courtier et al. 1995; Chadwick et al. 2006; Valley and Willard 2006).  
Allelic differences in Xce in expression bias cluster into three groups with strength 
order Xcea < Xceb < Xcec (Plenge et al. 2000). In inter-strain F1 mice, the X 
chromosome with a stronger allele will have higher probability to be the active X 
chromosome (Plenge et al. 2000).  Our observation of the allele-specific expression 
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pattern of Xist in B6 and CAST crosses is consistent with the fact that the B6 Xce 
allele belongs to the Xceb group and the CAST allele is an Xcec allele (Plenge et al. 
2000). So we expect a strong eQTL effect with higher expression of the B6 allele of 
Xist. From the AKR and PWD crosses, it is known that the strength of the AKR Xce 
allele is somewhere between Xceb and Xcec. Given our data, we conclude that the 
PWD Xce allele is stronger than that of AKR. The 90% allele-specific expression ratio 
seems to be unexpectedly high, but note that the bias in the final X inactivation ratio 
need not match the allele-specific expression of Xist.  The Xist transcript is only 
expressed from the inactive X chromosome but the two Xist alleles may be expressed 
quantitatively at different levels, and the expression levels measured here are from 
heterogeneous pools of cells.  It could be that the AKR allele expression level is 
higher in cells with inactive X from AKR strain than the PWD allele expression level 
in cells with inactive X from PWD strain, but the PWD expression level is sufficient 
to maintain the X inactivation status. Parent-of-origin influences of Xce on X 
chromosome biased allelic inactivation had been reported in heterozygous F2 mice 
(not significant in F1) in B6-CAST crosses (Chadwick and Willard 2005). Since the 
Xce is a strain-specific DNA sequence feature rather than an epigenetic mark, it is 
expected to be manifested as an eQTL effect. The parent-origin-effect of skewed 
random X inactivation that we observed cannot be explained as a canonical Xce effect.  
 
We found the mouse orthologs of human genes that escape X inactivation (Ctps2, 
Maoa, Syap1, Usp9x, Zfx, Ikbkg, Prkx, Crsp2, Fundc1, Gpm6b, Ofd1, Sh3bgrl, L1cam) 
and the ones that partially escape X inactivation (Phf6, Nxt2, Hcfc1) (Carrel and 
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Willard 2005), are subject to X inactivation in mouse. The mouse orthologs of human 
genes subject to X inactivation (Taf1, Syn1, Plxna3, Nudt11, Zbtb33, Wdr13, Rbmx, 
Uba1, Cstf2, Ids) are also subject to X inactivation in mouse (Figure 41A, Figure 43 
and Figure 44). This is consistent with the previous findings that human has more 
genes that escape X inactivation than mouse. We also confirmed 11 of the above genes 
in the B6 x CAST strain combination (Figure 42A). Prkx, a mouse X-inactivation 
escaper candidate gene whose X inactivation status is not determined (Disteche et al. 
2002), is found to be a non-escaper in our data.  
 
Sampling effect of X inactivation during early development in the mouse brain 
We observed significant variation in allelic expression for the X-linked genes among 
36 normal F1 individuals in the reciprocal crosses of AKR and PWD, as well as 22 F1 
individuals in B6 and CAST reciprocal crosses. Because we do not see the same 
amount of variation for the autosomal control genes, we conclude that the variation in 
expression is due to a cellular sampling effect at the time of X inactivation (see also 
(Amos-Landgraf et al. 2006)). We found that the among-individual sampling effect 
(explaining 30.9% of the total allele-specific variance in the AKR-PWD cross) is 
larger than the parent-of-origin effect (explaining 14.3% of the total allele-specific 
expression variance).  
 
The X inactivation process starts at an early stage (approximately at E6.5) when there 
are only a few brain-forming cells, and once X inactivation occurs in a cell, the X 
inactivation status is retained by the daughter cells. Here, we refer to the average 
 181 
number because the X inactivation does not initiate instantaneously but instead occurs 
over a short period of time. The average number of brain-forming cells at the time of 
X inactivation can be estimated from the among-individual sampling variance of 
relative gene expression levels (Amos-Landgraf et al. 2006). The larger the variation 
among individuals, the smaller number of cells there must have been during X 
inactivation. By simulating a random process of X-inactivation, and matching the 
observed and simulated variance, we estimated the average number of brain precursor 
cells during the time of X inactivation (Figure 45). 
 
Parent-of-origin effect is chromosome-wide 
Analysis of the distribution of allele-specific expression of a set of X-linked genes 
allowed us to quantify the parent-of-origin effect for the X chromosome (Figure 43). 
We observed that the X-linked non-escaper genes in mouse showed a significant 
parent-of-origin effect, as well as larger sampling variation. In contrast, for the known 
escapers, we did not see a significant parent-of-origin effect and the sampling variance 
of gene expression is much smaller. The data from the 33 X-linked genes assayed are 
consistent with the parent-of-origin effect being chromosome-wide. 
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Figure 45. Estimation of the number of brain-forming cells at the time of X 
inactivation in mouse. Given the observed variance among individuals in 
relative expression levels, we calculated the maximum likelihood estimate for 
the number of cells present at the time of X inactivation (assuming X 
inactivation occurs at a single point in time and is irreversible). For the PWD x 
AKR cross, the average number of brain forming cells at the time of X 
inactivation is estimated to be 58, with 95% confidence interval from 37 to 123. 
For the AKR x PWD cross, the estimated number is 54, with 95% confidence 
interval from 37 to 128. The cell numbers estimated from the two reciprocal 
crosses are thus consistent with each other, and numerical simulations were 
also consistent with these results. 
(A). Estimation of number of brain-forming cells at the time of X inactivation in 
F1 progeny of the PWD x AKR cross. 
(B). Estimation of number of brain-forming cells at the time of X inactivation in 
F1 progeny of the AKR x PWD cross. 
Binomial sampling was done with different sample sizes of brain-forming cells 
(x-axis) and for each sample the . The Y-axis is the simulated mean variance. 
The observed mean variance with 95% confidence interval is labeled. 
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Discussion 
 
Is random X inactivation truly “random”? 
Following the initial discovery that dosage compensation is accomplished in mammals 
by X inactivation (Lyon 1961), the process has been considered to occur through a 
random process in the embryonic tissues of eutherian mammals. This implies that each 
cell has an equal probability to inactivate either the paternal or the maternal copy of 
the X chromosome during random X inactivation (assuming equal influence of the two 
parental Xce alleles). Our data provide clear evidence that X inactivation can depart 
from a strictly random pattern, and in the mouse brain we find a small but significant 
and consistent preferential bias to inactivate the paternal X. The result is robust across 
multiple individual mice from two sets of reciprocal crosses. The average ratio of 
inactivated paternal and maternal X chromosomes is not 50:50. Instead, there is about 
6% preferential paternal bias in X inactivation, a bias small enough that it is easy to 
see why it has been overlooked. At present it is not clear whether the bias is driven by 
incomplete erasure of the paternal X imprint (Lee et al. 1996; Jaenisch et al. 1998; Lee 
and Lu 1999), or whether the signal is totally erased and there follows a bias in the X-
inactivation process itself.  Formally there is also the possibility that the bias that we 
observe toward excess maternal expression could be due to preferential 
growth/proliferation of cells with the maternal active X, but the absence of any known 
mechanism that might drive this bias reduces its plausibility. The ultimate 
experimental answer will come from examination of differential X chromosome 
expression in appropriate tissues at the single cell level. 
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Further understanding the process of X inactivation 
Two hypotheses may explain the preferential paternal X inactivation. First, the short 
time interval during the transition from imprinted X inactivation to random X 
inactivation in embryonic tissues may leave a residual imprint. During imprinted X 
inactivation, it is known that there might be a residual imprint on the maternal X 
chromosome that keeps it active, probably by repressing the Xist transcription in cis 
(Heard and Disteche 2006). If this is the case, then during reactivation of the paternal 
X chromosome, the short time interval may be insufficient to completely reset the 
Xist/Tsix status by erasure of its epigenetic marks. The other possibility is that erasure 
of Xist from the X chromosome could be complete after imprinted X inactivation, but 
that during the random X inactivation, by some unknown mechanism, the maternal X 
chromosome has a slightly higher chance to remain active. Additional experiments are 
needed to elucidate the mechanism of preferential paternal X inactivation in mouse.  
 
Evolutionary considerations 
Both marsupials and eutherian mammals achieve dosage compensation through X 
inactivation. For marsupials, the imprinted X inactivation status is retained in both the 
extraembryonic and embryonic tissues during development and later throughout 
adulthood (Cooper et al. 1990). Because the maternal expression of the X-linked genes 
is not 100%, the imprinted X inactivation is called incomplete or leaky X inactivation.  
Here, we found that the random X inactivation in eutherian mammals is not 50:50, but 
instead there is preferential paternal inactivation, suggesting the possibility that the 
imprinted X inactivation represents a remnant of the ancestral state. Classical 
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evolutionary theory suggests that after the differentiation of the X and Y sex 
chromosomes, the Y chromosome degenerates, necessitating a means for adjusting 
dosage to resolve the X chromosome dosage imbalance (Vicoso and Charlesworth 
2006; Straub and Becker 2007) .   One possible mechanism for X inactivation is to 
always inactivate one of the parental X chromosomes. The inactivated X cannot be the 
maternal X because the only X chromosome that males possess is maternal. Paternal 
X-inactivation, as is found in marsupials, may represent the ancestral form of 
mammalian dosage compensation (Namekawa et al. 2007), although it is formally 
possible that the common ancestor of marsupials and eutherian mammals lacked 
dosage compensation, and that both lineages developed their own dosage 
compensation mechanisms independently.  
 
Compared to random X inactivation, imprinted X inactivation runs a greater risk of 
error. If a recessive deleterious or lethal allele is transmitted from the mother, the 
fitness of the offspring will be severely reduced. For random (or nearly random) X 
inactivation, there are still half the cells expressing the normal allele.  By expressing 
one of the two parental alleles in different cells, both dosage compensation and the 
problem of X hemizygosity are solved. As mentioned before, in marsupials the 
imprinted X inactivation is not complete, and we discovered that there is also 
preferential paternal X inactivation in mouse brain, but with much smaller degree of 
maternal bias than in marsupials. If the common ancestor of eutherian mammals and 
marsupials had some form of imprinted X inactivation, then the most parsimonious 
explanation would be that during evolution, there has been a trend from complete 
 187 
imprinted X inactivation in the ancestor of all mammals, to leaky imprinted X 
inactivation in marsupials, whereas the lineage leading to eutherian mammals 
developed random X inactivation with slight maternal bias.  
 
Caveats for identifying X-linked imprinted genes outside extra-embryonic tissue 
It is known that many imprinted genes are derived from retro-transposition events with 
the origin from the X chromosome, such as Nap1l5, U2af1-rs1, and Inpp5f_v2. 
Currently, there are four documented X-linked imprinted genes. Xist and Tsix, are 
imprinted in mouse, and they are imprinted in the extra-embryonic tissues (Kay et al. 
1994; Sado et al. 2001). Rhox5, is imprinted at a preimplantation stage before the 
completion of X inactivation (Kobayashi et al. 2006). A candidate imprinted gene, 
Xlr3b was found by comparing the expression of 39, XmaternalO and 39, XpaternalO mice 
(Davies et al. 2005). The genes Xlr3b, Xlr4b  and  Xlr4c are were examined in 
normal female neonatal brain from reciprocal cross F1 progeny, and their imprinting 
status was variable.  Xlr3b is clearly not imprinted in our data (not shown). In our 
previous RNA-seq study, we found four X-linked genes (Syn1, Plxna3, Phf6 and 
Ctps2, Figure 38) with a significant parent-of-origin effect on expression. However, a 
subsequent study described in this paper showed that they are not imprinted, but the 
skewed expression ratio instead arose by a sampling effect of X inactivation. Further 
attempts to discover X-linked imprinted genes should use a larger sample size to 
distinguish and verify X-linked imprinted genes from the confounding of the 
preferential paternal X inactivation and the sampling effect.  
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Cataloging X inactivation escapers in mouse and human  
To further understand the X inactivation process and the evolution of the X 
chromosome, it is essential to tabulate an exhaustive catalog of genes that escape X 
inactivation in both human and mouse. Unfortunately, there is no direct method to do 
this in a normal single cell. For an RNA gene that works in cis, such as Xist, it is 
possible to count the foci in single cells using a fluorescent staining approach (Lee 
2000). However, for most of the X transcripts, the single cell method is too laborious 
to be applied at a genome-wide scale. Human-murine (Carrel and Willard 2005) fusion 
cell lines and human primary fibroblasts have been used with great success to discover 
human genes that escape X inactivation. In mice, the genes that escape X inactivation 
were found using T(X;16)16H (T16H) translocations. Currently, there is no published 
chromosome-wide survey of the X inactivation status of all X-linked genes in mice, 
although methods like ours and that of Yang et al. (Yang et al. 2010) could easily be 
extended to cover the entire X. Based on the known X inactivation escapers in mouse 
and human, 15% of X-linked genes in human escape X inactivation, whereas previous 
efforts found only several escapers in mouse (Brown and Greally 2003), and Yang et 
al. (Yang et al. 2010) estimate that 3.3% of X linked genes escape X inactivation in 
mouse cultured cells.  In this paper, we found many orthologs of known human 
escapers to be non-escapers in mouse (all the non-escaper genes tested by both our 
method and Yang et al.’s were concordant with respect to escaper status), suggesting 
that mouse does have fewer escapers that does human. Although the method presented 
here is an indirect one, it opens the door to examine the X inactivation status for any 
polymorphic X-linked gene in normal mice in any tissue.   
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Conclusions 
 
Analysis of allele-specific transcript abundance in tissues of F1 progeny from 
reciprocal crosses of mouse strains provides a remarkably informative way to dissect 
the sources of variation among individuals.   A large part of the inter-individual 
variation in relative expression of the two X chromosomes is due to a sampling effect 
determined by the number of cells in the tissue at the time of X inactivation – fewer 
cells results in larger sampling variance.  The promoters from the parental mouse 
strains may differ in their efficiency, producing a bias in expression that follows the 
allelic state in both reciprocal crosses.  Such eQTL effects are widespread.   The 
Xce effect also may lend a chromosome-wide bias to the choice of inactivated X.  
Escapers of X inactivation are readily identified by this method, and we confirm the 
relative paucity of X inactivation escapers in mouse compared to human.  On top of 
all of these factors, this study establishes the existence of a significant parent-of-origin 
effect, showing that the paternal X chromosome has a roughly 6% greater tendency 
toward being inactivated in the mouse brain.  This observation is consistent with an 
evolutionary model that posits paternal X inactivation as an ancestral state. 
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